Carsten Bokemeyer

Q: What Schools Are Affiliated With Carsten Bokemeyer

Carsten Bokemeyer is affiliated with the following schools: Monash University, Université catholique de Louvain, Humboldt University of Berlin, University of Rostock, University of Marburg, University of Stuttgart, Hannover Medical School, Cardiff University, University of Hamburg, University of Greifswald

Carsten Bokemeyer's AcademicInfluence.com Rankings

Carsten Bokemeyer

Philosophy

#3953

World Rank

#6294

Historical Rank

Logic

#1524

World Rank

#2297

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Carsten Bokemeyer's Degrees

Doctorate Medicine University of Hamburg

Why Is Carsten Bokemeyer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Carsten Bokemeyer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Platinum-based chemotherapy plus cetuximab in head and neck cancer. (2008) (2913)
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. (2009) (1610)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 (2020) (1550)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). (2008) (987)
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. (2004) (783)
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. (2010) (779)
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. (2011) (757)
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. (2008) (670)
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. (2003) (654)
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. (2008) (556)
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials. (2012) (540)
Guidelines on Testicular Cancer: 2015 Update. (2015) (525)
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). (2004) (476)
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. (2006) (467)
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial (2010) (466)
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. (2009) (438)
Guidelines on testicular cancer. (2005) (428)
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. (2002) (398)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. (2007) (398)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. (2004) (390)
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. (2004) (383)
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. (2008) (368)
EAU guidelines on testicular cancer: 2011 update. (2011) (344)
Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab. (2012) (330)
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. (2005) (329)
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. (1996) (296)
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. (2011) (287)
KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience (2008) (274)
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer (2012) (268)
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. (1998) (249)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy (2011) (248)
Evaluation of long-term toxicity after chemotherapy for testicular cancer. (1996) (248)
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. (2009) (245)
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013) (241)
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. (2001) (240)
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection (2000) (237)
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells (2004) (236)
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy. (2010) (234)
Chemotherapy for renal cell carcinoma. (1999) (229)
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer (2011) (223)
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer. (2015) (216)
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. (1994) (212)
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up (2018) (205)
Platinum organ toxicity and possible prevention in patients with testicular cancer (1999) (199)
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. (2008) (191)
HER-2 amplification is highly homogenous in gastric cancer. (2010) (189)
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab. (2013) (180)
Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment (2005) (179)
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. (1998) (177)
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. (2013) (176)
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study (2019) (174)
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. (2008) (173)
Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance (2010) (170)
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952. (2003) (168)
Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience (1999) (166)
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. (2007) (164)
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. (2009) (163)
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. (2000) (162)
Testicular germ cell tumours (2016) (160)
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming (2008) (156)
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. (1999) (153)
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. (2008) (153)
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. (2001) (151)
A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. (2009) (150)
Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. (2005) (149)
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. (1995) (149)
Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. (2005) (145)
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. (2017) (143)
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. (2009) (142)
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. (2001) (140)
Secondary neoplasms following treatment of malignant germ cell tumors. (1993) (137)
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. (2003) (136)
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. (1996) (134)
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. (2008) (134)
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. (2004) (134)
Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer (2010) (134)
Stem cell factor as a novel diagnostic marker for early malignant germ cells (2008) (134)
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. (1999) (134)
Treatment of testicular cancer and the development of secondary malignancies. (1995) (133)
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings. (2011) (132)
Long-term effects on sexual function and fertility after treatment of testicular cancer (1999) (131)
Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer (2009) (131)
Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features (2001) (129)
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. (2001) (127)
Active surveillance is the preferred approach to clinical stage I testicular cancer. (2013) (123)
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group. (2007) (121)
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. (2010) (121)
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. (2005) (120)
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+). (2013) (120)
Molecular determinants of treatment response in human germ cell tumors. (2003) (119)
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). (2011) (119)
Treatment outcome according to tumor RAS mutation status in OPUS study patients with metastatic colorectal cancer (mCRC) randomized to FOLFOX4 with/without cetuximab. (2014) (117)
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients (2008) (115)
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro (2003) (115)
A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer (2000) (115)
The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis. (2015) (115)
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck (2010) (112)
Quality of life, psychological burden, needs, and satisfaction during specialized inpatient palliative care in family caregivers of advanced cancer patients (2017) (112)
Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. (2002) (112)
Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study (2007) (112)
Treatment outcome of patients with brain metastases from malignant germ cell tumors (1999) (111)
Treatment of brain metastases in patients with testicular cancer. (1997) (111)
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. (1991) (111)
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway (2008) (110)
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials (2004) (109)
Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. (2000) (107)
High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer. (2013) (107)
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. (1995) (106)
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database. (2016) (106)
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group. (2008) (106)
Cardiotoxicity of 5‐fluorouracil in combination with folinic acid in patients with gastrointestinal cancer (1993) (105)
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer (2015) (105)
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. (2002) (104)
Cancer‐testis antigen expression and its epigenetic modulation in acute myeloid leukemia (2011) (101)
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. (2002) (100)
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors. (1996) (99)
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies (1998) (98)
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma (1994) (98)
Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis (2010) (98)
High Ki67 expression is an independent good prognostic marker in colorectal cancer (2015) (96)
Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature. (2016) (95)
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines† (2018) (95)
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. (2001) (95)
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. (2012) (94)
Cetuximab with chemotherapy (CT) as first-line treatment for metastatic colorectal cancer (mCRC): Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation status. (2010) (94)
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. (2007) (94)
Global meaning and meaning-related life attitudes: exploring their role in predicting depression, anxiety, and demoralization in cancer patients (2011) (94)
Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab. (2012) (93)
Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. (2013) (93)
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours (2005) (93)
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC). (2006) (93)
Tolerance to chemotherapy in elderly patients with cancer. (2007) (91)
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation (2011) (91)
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma (2002) (91)
[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial. (2008) (91)
Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites? (2009) (91)
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation (2008) (89)
Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. (1997) (89)
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells (2010) (89)
Is advanced cancer associated with demoralization and lower global meaning? The role of tumor stage and physical problems in explaining existential distress in cancer patients (2012) (88)
Therapy‐related malignancies following treatment of germ cell cancer (1999) (88)
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. (1996) (87)
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors (2019) (86)
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients. (2010) (86)
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers. (2010) (84)
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database. (2015) (83)
Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. (1997) (83)
Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma (2009) (83)
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme. (2013) (82)
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project (2018) (82)
A Randomized Trial Comparing the Nephrotoxicity of Cisplatin/Ifosfamide-Based Combination Chemotherapy with or without Amifostine in Patients with Solid Tumors (2000) (81)
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors. (2003) (80)
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma. (2001) (79)
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer (2009) (79)
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas (2011) (78)
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects (2015) (78)
Gene amplification in ductal carcinoma in situ of the breast (2010) (78)
Cisplatin nephrotoxicity and protection by silibinin. (1996) (78)
Germ cell lineage differentiation in non‐seminomatous germ cell tumours (2006) (77)
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines (2011) (77)
Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform (2011) (75)
Recent advances in management of patients with platinum‐refractory testicular germ cell tumors (2006) (75)
Marked heterogeneity of ERG expression in large primary prostate cancers (2013) (74)
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET (2002) (74)
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study. (2011) (73)
Cytogenetics of extramedullary manifestations in multiple myeloma (2013) (72)
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer (2012) (72)
1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986 (2003) (72)
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. (2003) (71)
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors. (2011) (71)
A phase I/II study of sequential, dose‐escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas (1997) (71)
Late toxicity following curative treatment of testicular cancer. (1999) (70)
Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients (2015) (69)
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy. (2018) (68)
Crosstalk between cancer and haemostasis (2012) (68)
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. (2004) (68)
Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma (2006) (68)
Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer (2010) (67)
Role of P53 and MDM2 in treatment response of human germ cell tumors. (2002) (66)
Acute psychological stress alerts the adaptive immune response: Stress-induced mobilization of effector T cells (2006) (66)
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation (2008) (66)
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling. (2000) (65)
Endocrinological late effects after chemotherapy for testicular cancer. (1996) (65)
Decrease of CD4+FOXP3+ T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor (2010) (65)
Exercise training in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot study (2014) (64)
Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. (2006) (63)
Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. (2005) (63)
Cancer of the Testis (2011) (63)
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group. (2016) (63)
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel. (2017) (63)
Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians (2013) (62)
Relationship between symptom burden, distress, and sense of dignity in terminally ill cancer patients. (2014) (62)
Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism. (2017) (61)
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. (2009) (61)
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. (2009) (61)
Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study) (2016) (61)
The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience (2002) (60)
Elevated pretreatment serum concentration of YKL‐40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer (2010) (60)
p53 overexpression as a prognostic factor for advanced stage bladder cancer. (1995) (60)
Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey (2006) (59)
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. (2000) (59)
Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? (2011) (59)
CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives. (2013) (59)
Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization (2015) (59)
Anxiety and depression in caregivers of terminally ill cancer patients: impact on their perspective of the patients' symptom burden. (2013) (58)
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. (2004) (58)
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer (2016) (58)
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium (2021) (58)
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial. (2015) (58)
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma (2006) (58)
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer (2015) (57)
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma (2016) (57)
Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes (2003) (56)
Current standards and new trends in the primary treatment of colorectal cancer. (2011) (56)
Diarrhea and constipation. (2000) (56)
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. (2018) (55)
Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial (2013) (55)
Rationale and Design of the Hamburg City Health Study (2019) (55)
Physical exercise and therapy in terminally ill cancer patients: a retrospective feasibility analysis (2014) (55)
Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial. (2005) (55)
Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody Trastuzumab. (1999) (54)
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy. (1998) (54)
Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma (2012) (53)
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology (2020) (53)
Autoantibodies against tumor-related antigens: incidence and biologic significance. (2010) (53)
An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body. (2010) (53)
Single‐agent carboplatinum for advanced seminoma a phase II study (1993) (52)
NY‐CO‐58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer (2010) (52)
Experimental metastasis and primary tumor growth in mice with hemophilia A (2006) (52)
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. (1998) (52)
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer (2002) (51)
Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. (2012) (51)
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro. (2012) (51)
Peritumoral eosinophils predict recurrence in colorectal cancer (2015) (51)
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B (2017) (51)
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer (2019) (51)
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma (2011) (51)
Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro (2011) (50)
Actual and Predicted Survival Time of Patients With Spinal Metastases of Lung Cancer: Evaluation of the Robustness of the Tokuhashi Score (2011) (50)
Psychological burden in family caregivers of patients with advanced cancer at initiation of specialist inpatient palliative care (2019) (50)
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option (2018) (50)
Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion. (2011) (50)
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial (2003) (50)
Guanidine Alkaloids from the Marine Sponge Monanchora pulchra Show Cytotoxic Properties and Prevent EGF-Induced Neoplastic Transformation in Vitro (2016) (49)
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (2008) (49)
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients (1999) (49)
Involvement of E‐cadherin and β‐catenin in germ cell tumours and in normal male fetal germ cell development (2004) (49)
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium (2021) (49)
Bilateral testicular tumours: prevalence and clinical implications. (1993) (49)
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung (2012) (49)
Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. (1995) (48)
Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens? (2008) (48)
Determination of PD-L 1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1 / PD-L 1 Inhibitors (2019) (48)
Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation. (2010) (48)
Physical activity, quality of life, and the interest in physical exercise programs in patients undergoing palliative chemotherapy (2011) (48)
Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies (2012) (48)
A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation (2014) (47)
Effect of KRAS and NRAS mutations on treatment outcomes in patients with metastatic colorectal cancer (mCRC) treated first-line with cetuximab plus FOLFOX4: New results from the OPUS study. (2014) (47)
Colorectal Cancer in the Elderly (2003) (47)
Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis (2007) (47)
EAU Guidelines on testicular cancer, 2011 update (2012) (47)
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer. (1997) (46)
Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors (2014) (46)
Catumaxomab – trifunctional anti-EpCAM antibody used to treat malignant ascites (2010) (46)
A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer. (2007) (46)
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (2008) (45)
Influence of KRAS G13D mutations on outcome in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy with or without cetuximab. (2011) (45)
Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors. (2006) (45)
Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer. (2014) (45)
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer (2005) (44)
Antiangiogenic treatment with endostatin inhibits progression of AML in vivo (2005) (44)
Paclitaxel-induced radiation recall dermatitis. (1996) (43)
Biological Relevance and Therapeutic Potential of the Hypusine Modification System* (2015) (43)
Aaptamines from the Marine Sponge Aaptos sp. Display Anticancer Activities in Human Cancer Cell Lines and Modulate AP-1-, NF-κB-, and p53-Dependent Transcriptional Activity in Mouse JB6 Cl41 Cells (2014) (43)
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer. (1997) (43)
ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts. (2015) (43)
Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis (1996) (42)
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. (2007) (42)
6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status (2009) (42)
Anxiety and depression in long-term testicular germ cell tumor survivors. (2016) (42)
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. (2005) (42)
Role of interleukin 16 in multiple myeloma. (2012) (42)
Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge (2005) (42)
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation (2001) (42)
Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection (2017) (42)
The role of [18F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of postchemotherapy residual masses in metastatic germ cell tumors—prospects for management (2004) (42)
Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines (2004) (41)
Mycalamide A Shows Cytotoxic Properties and Prevents EGF-Induced Neoplastic Transformation through Inhibition of Nuclear Factors (2012) (41)
Chemotherapy in elderly patients with colorectal cancer. (2001) (41)
Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer. (2011) (40)
Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer. (2007) (40)
Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias (2016) (40)
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer (2002) (39)
Thyroid toxicity of treatment for Hodgkin's disease (2000) (39)
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma. (1999) (39)
Extragonadal germ cell tumors: relation to testicular neoplasia and management options (2003) (39)
Sexual function and fertility after treatment of testicular cancer (2000) (39)
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia. (2010) (39)
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. (2012) (39)
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors (2000) (39)
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper (2020) (39)
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells (2017) (39)
Absence of c‐KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer (2002) (38)
Cyclin D1 gene amplification is highly homogeneous in breast cancer (2014) (38)
Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines (2005) (38)
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. (2006) (38)
New insights into the pathology and molecular biology of human germ cell tumors (2004) (37)
Treatment of lung cancer in elderly part II: small cell lung cancer. (2003) (37)
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer. (2010) (37)
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells (2018) (37)
Expression of E-cadherin in primary prostate cancer: correlation with clinical features. (1998) (36)
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors (2000) (36)
TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis (2010) (36)
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma (2014) (36)
Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers (2007) (36)
Anaemia in cancer patients: pathophysiology, incidence and treatment (2005) (36)
T‐cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker (2017) (35)
Y chromosome loss is a frequent early event in urothelial bladder cancer (2010) (35)
Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia (2016) (35)
A LARGE OPEN-LABEL, NON-COMPARATIVE, PHASE III STUDY OF THE MULTI-TARGETED KINASE INHIBITOR SORAFENIB IN EUROPEAN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (2008) (35)
High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer. (2015) (35)
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer. (2001) (34)
A ‘telomere-associated secretory phenotype’ cooperates with BCR-ABL to drive malignant proliferation of leukemic cells (2014) (34)
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia. (2010) (34)
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. (1998) (34)
Treatment of patients with cisplatin‐refractory testicular germ‐cell cancer (1999) (34)
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome (2010) (34)
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide. (2000) (34)
How to select the optimal treatment for first line metastatic colorectal cancer. (2014) (34)
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg (2020) (33)
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer. (1997) (33)
Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas. (2003) (33)
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane (2006) (33)
Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases. (2009) (33)
Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs. (1994) (33)
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database. (2017) (32)
Xeroderma Pigmentosum Group A Protein and Chemotherapy Resistance in Human Germ Cell Tumors (2003) (32)
Prevalence and Predictors of Distress, Anxiety, Depression, and Quality of Life in Bereaved Family Caregivers of Patients With Advanced Cancer (2020) (32)
Genitourinary tumors, non-prostate (2012) (31)
Homogeneous EGFR amplification defines a subset of aggressive Barrett’s adenocarcinomas with poor prognosis (2010) (31)
A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia (2014) (31)
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial. (1995) (31)
Pretrichodermamides D–F from a Marine Algicolous Fungus Penicillium sp. KMM 4672 (2016) (31)
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels (2005) (31)
Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report (2008) (31)
Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma. (2010) (31)
Management of Cytotoxic Extravasation - ASORS Expert Opinion for Diagnosis, Prevention and Treatment (2013) (31)
Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines. (2007) (31)
Konsensus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon- und Rektumkarzinom vom 11.3.1994 (1994) (31)
Erythropoietins should be used according to guidelines. (2008) (31)
Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target. (2012) (30)
Treatment of brain metastases from germ cell tumors. (2011) (30)
Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity. (2014) (30)
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216). (2020) (30)
Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy (2004) (30)
Zusammenspiel von Tumorwachstum und Hämostaseaktivierung – Bedeutung von Tissue-Faktor für Tumorbiologie und tumorassoziierte Thrombose (2012) (30)
Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study (2015) (30)
Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies (2010) (30)
Platinum-refractory germ cell tumors: an update on current treatment options and developments (2017) (29)
Late adverse effects and quality of life in survivors of testicular germ cell tumour (2021) (29)
The Local Cytokine and Chemokine Milieu within Malignant Effusions (2008) (29)
Mutational landscape reflects the biological continuum of plasma cell dyscrasias (2017) (29)
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL (2014) (29)
Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia (2003) (29)
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. (2022) (29)
Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists (2012) (29)
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group. (2016) (28)
Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study) (2016) (28)
Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients (2011) (28)
The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma. (2010) (28)
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors. (2010) (28)
The effects of music therapy in patients with high‐dose chemotherapy and stem cell support: a randomized pilot study (2017) (28)
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature. (2012) (28)
Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocol. (2014) (28)
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs (2015) (27)
A Pilot Study of Docetaxel and Trofosfamide as Second-Line ‘Metronomic’ Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) (2008) (27)
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer. (2013) (27)
Therapeutic approaches for refractory germ cell cancer (2018) (27)
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia (2017) (27)
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells (2017) (27)
Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer. (2016) (27)
A case of pulmonary carcinosarcoma (squamous cell carcinoma and osteosarcoma) treated with cisplatin and doxorubicin. (2006) (26)
Investigational targeted therapies for the treatment of testicular germ cell tumors (2016) (26)
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM). (2022) (26)
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. (2015) (26)
Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update. (2011) (26)
Biomarker potential of EGFR gene copy number by FISH in the phase III EXTREME study: Platinum-based CT plus cetuximab in first-line R/M SCCHN. (2009) (26)
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. (1993) (26)
Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension (2017) (26)
Efficacy of chemotherapy plus cetuximab according to metastatic site in KRAS wild-type metastatic colorectal cancer (mCRC): Analysis of CRYSTAL and OPUS studies. (2011) (25)
Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416 (2006) (25)
Bone metastases in germ cell tumor patients (2012) (25)
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment (2021) (25)
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma. (1996) (25)
Loss of RNA‐binding motif protein 3 expression is associated with right‐sided localization and poor prognosis in colorectal cancer (2016) (25)
3004 ORAL Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) in the first-line treatment of metastastic colorectal cancer (mCRC): a large-scale phase II study, OPUS (2007) (25)
Reducing the burden of bone metastases (2013) (25)
Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren Ergebnisse einer Update-Konferenz auf Grundlage evidenzbasierter Medizin (EBM) (2000) (24)
Novel Algorithm for More Accurate Calculation of Renal Function in Adults with Cancer (2008) (24)
Treatment of advanced germ cell tumours by dose intensified chemotherapy with haematopoietic growth factors or peripheral blood stem cells (PBSC). (1993) (24)
Venous Thromboembolic Events in Germ Cell Cancer Patients Undergoing Platinum-Based Chemotherapy (2013) (24)
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer. (1999) (24)
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones (2019) (24)
Phase I trial of SU14813 in patients with advanced solid malignancies. (2011) (24)
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group (2018) (23)
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial (2009) (23)
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours. (1992) (23)
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus (2004) (23)
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC) (2013) (23)
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma (2003) (23)
MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer. (2010) (23)
Supportive care in patients with cancer during the COVID-19 pandemic (2020) (23)
High level of Ets‐related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers (2012) (23)
Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study). (2017) (23)
Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance. (2014) (23)
Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative (2008) (23)
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial (2011) (23)
Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer. (2010) (23)
Favored subjects and psychosocial needs in music therapy in terminally ill cancer patients: a content analysis (2016) (22)
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma (2020) (22)
Critical Imbalance of TNF-α and Soluble TNF Receptor 1 in a Patient with Macrophage Activation Syndrome: Potential Implications for Diagnostics and Treatment (2012) (22)
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19) (2021) (22)
Lectin histochemistry of metastatic adenocarcinomas of the lung. (2007) (22)
Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair. (2012) (22)
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia. (2003) (22)
Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy. (2001) (22)
Detrimental social interactions predict loss of dignity among patients with cancer (2016) (22)
Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors: past, present, and future considerations (2019) (22)
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer (2017) (22)
Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301) (2008) (22)
Is Continuous 24-Hour Infusion of 5-Fluorouracil plus High-Dose Folinic Acid Effective in Patients with Progressive or Recurrent Colorectal Cancer? (1998) (22)
Role of Postchemotherapy Surgery in the Management of Patients With Liver Metastases From Germ Cell Tumors (2005) (22)
Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer (2012) (22)
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer. (2008) (22)
Salvage chemotherapy in relapsed germ cell tumors (2001) (22)
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine. (2007) (22)
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217) (2020) (21)
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting (2013) (21)
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors (2007) (21)
Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy. (2008) (21)
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer (2015) (21)
Prospective Study on Music Therapy in Terminally Ill Cancer Patients during Specialized Inpatient Palliative Care. (2016) (20)
Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial. (1992) (20)
Use of Hematopoietic Growth Factors in Elderly Patients Receiving Cytotoxic Chemotherapy (2002) (20)
Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor. (1994) (20)
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy. (2018) (20)
Evaluation of a program for routine implementation of shared decision-making in cancer care: study protocol of a stepped wedge cluster randomized trial (2018) (20)
Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy. (2008) (20)
Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT trial. (2020) (20)
CT hepatic and splenic appearances with sarcoidosis. (1996) (20)
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial. (2015) (20)
Aprepitant as Salvage Therapy in Patients with Chemotherapy-Induced Nausea and Emesis Refractory to Prophylaxis with 5-HT3 Antagonists and Dexamethasone (2006) (20)
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer (2005) (19)
Protein-protein-interaction Network Organization of the Hypusine Modification System* (2012) (19)
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study (2016) (19)
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation (2014) (19)
Familial occurrence of Leydig cell tumors: a report of a case in a father and his adult son. (1993) (19)
Metastatic leydig-cell tumors of the testis - report of 4 cases and review of the literature. (1993) (19)
Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma. (2012) (19)
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer (2014) (19)
Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma. (2008) (19)
Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia (2016) (19)
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages (2021) (19)
PTEN deletion is rare but often homogeneous in gastric cancer (2012) (19)
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters (2005) (19)
Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line. (2008) (19)
Palliative treatment of germ cell cancer. (2018) (19)
SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11). (2019) (19)
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer (2020) (19)
Recent strategies for the use of paclitaxel in the treatment of urological malignancies (1998) (18)
Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study (2017) (18)
Anti‐migratory activity of marine alkaloid monanchocidin A – proteomics‐based discovery and confirmation (2016) (18)
Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: Secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples (2014) (18)
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology. (1997) (18)
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy (2001) (18)
Adjuvant chemotherapy after complete resection of non-small cell lung cancer. (2008) (18)
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial (2021) (18)
Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer. (2010) (18)
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]. (2000) (18)
Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia. (2008) (18)
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer (2021) (18)
The impact of social factors on outcomes in patients with bleeding disorders (2016) (18)
Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse (2014) (18)
The Preference to Discuss Expected Survival Is Associated with Loss of Meaning and Purpose in Terminally Ill Cancer Patients. (2015) (18)
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer (2009) (18)
Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients. (2010) (17)
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study (2003) (17)
6079 Overall survival of patients with KRAS wild-type tumours treated with FOLFOX4± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study (2009) (17)
The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension (2019) (17)
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients (2020) (17)
Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension (2016) (17)
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'. (2020) (17)
PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases. (2007) (17)
Supportive care needs and service use during palliative care in family caregivers of patients with advanced cancer: a prospective longitudinal study (2020) (17)
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer. (1998) (17)
Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers (2015) (17)
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies (2019) (17)
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer (2015) (17)
Use of the Comprehensive Geriatric Assessment (CGA) in elderly patients (pts) with solid tumors to predict mortality. (2009) (17)
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Results of the safety run-in phase of the phase II AVETUX trial (AIO-KRK-0216). (2018) (17)
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy) (2009) (17)
Impact of taste and smell training on taste disorders during chemotherapy – TASTE trial (2019) (17)
Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments (2016) (17)
HER-2/neu analysis in breast cancer bone metastases (2009) (16)
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells (2018) (16)
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma. (2019) (16)
Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib. (2018) (16)
Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus (2014) (16)
Anemia impact and management: focus on patient needs and the use of erythropoietic agents. (2004) (16)
Symptom burden in long-term germ cell tumor survivors (2016) (16)
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway (2013) (16)
TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy? (2010) (16)
Current Trends in Chemotherapy for Metastatic Nonseminomatous Testicular Germ Cell Tumors (1998) (16)
Short report: High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study (1990) (16)
Exploring the gender dimension of problems and needs of patients receiving specialist palliative care in a German palliative care unit - the perspectives of patients and healthcare professionals (2019) (16)
Phase II Results of Ara-C and Idarubicin in Combination with the Selective Inhibitor of Nuclear Export (SINE) Compound Selinexor (KPT-330) in Patients with Relapsed or Refractory AML (2016) (16)
Single-Agent Carboplatinum for Advanced Seminoma (1993) (16)
Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. (1994) (15)
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience (2004) (15)
The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study (2014) (15)
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial (2012) (15)
Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation—a phase II study (2002) (15)
Detection of p53 gene alteration in renal‐cell cancer by micropreparation techniques of tumor specimens (1995) (15)
Isolated Limb Perfusion with Melphalan for the Treatment of Intractable Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type (2010) (15)
Gefitinib in Combination with Oxaliplatin and 5-Fluorouracil in Irinotecan-Refractory Patients with Colorectal Cancer: A Phase I Study of the Arbeits gemeinschaft Internistische Onkologie (AIO) (2008) (15)
Acute psychological stress increases peripheral blood CD3+CD56+ natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders (2013) (15)
Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma. (2020) (15)
Treatment of Relapsed Nonseminomatous Germ Cell Tumors with Vinorelbine: A Trial of the Phase 1/11 Study Group of the Association for Medical Oncology of the German Cancer Society (1993) (15)
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib. (2005) (15)
Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study (2014) (15)
Ethical challenges in family caregivers of patients with advanced cancer – a qualitative study (2020) (15)
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial (2004) (14)
No synergistic activity of epirubicin and interferon-α2b in the treatment of hepatocellular carcinoma (1995) (14)
Impact of early tumor shrinkage on long-term outcome in metastatic colorectal cancer (mCRC) treated with FOLFOX4 with or without cetuximab: Lessons from the OPUS trial. (2011) (14)
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer (2012) (14)
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer (2005) (14)
Current pharmacotherapy for testicular germ cell cancer (2019) (14)
Phase I study of gefitinib in combination with oxaliplatin and weekly 5-FU/FA (FUFOX) for second-/third-line treatment in patients (pts) with metastatic colorectal cancer (CRC) (2005) (14)
Amifostine does not alter the antitumor activity of cisplatin in a pre‐clinical model of testicular cancer (1996) (14)
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors – presentation of the CARE for CAYA-Program study protocol and associated literature review (2020) (14)
The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines (2008) (14)
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML (2021) (14)
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer (2016) (14)
Successful treatment of Mucor pneumonia in a patient with relapsed lymphoblastic leukemia after bone marrow transplantation. (1993) (14)
Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines. (2014) (14)
Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension (2015) (14)
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG) (2014) (13)
Pharmacotherapy of relapsed metastatic testicular cancer (2008) (13)
N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency (2014) (13)
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG). (1999) (13)
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer (2018) (13)
The developmental origin of cancers defines basic principles of cisplatin resistance. (2021) (13)
Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour. (1992) (13)
Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML (2021) (13)
Mitomycin C plus Infusional 5-Fluorouracil in Platinum-Refractory Gastric Adenocarcinoma: An Extended Multicenter Phase II Study (2007) (13)
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer (2020) (13)
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, ifosfamide (VIP) plus stem cell support in males with poor prognosis germ cell cancer (GCC): An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). (2010) (13)
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targeting (2020) (13)
Cytomegalovirus, Oxidative Stress and Inflammation as Interdependent Pathomechanisms: Need for Novel Therapeutic Strategies? (1998) (13)
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3) (2019) (13)
Outcome according to metastatic site in patients with KRAS wild-type tumors: Analysis from the CRYSTAL and OPUS studies. (2011) (12)
Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's disease. (1996) (12)
Giant aneurysm causing frontal lobe syndrome (1990) (12)
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial (2019) (12)
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group (2002) (12)
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma. (2000) (12)
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. (2018) (12)
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma (2021) (12)
Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus. (2013) (12)
Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors (2021) (12)
Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors (2009) (12)
Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial (2019) (11)
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia (2016) (11)
Chemotherapie des kolorektalen Karzinoms – welche Therapie ist bei älteren Patienten gerechtfertigt? (2001) (11)
Cetuximab combined with infusional 5-fluorouracil/folinic acid (5-FU/FA) and oxaliplatin in metastatic colorectal cancer (mCRC): A pooled analysis of COIN and OPUS study data. (2012) (11)
Relevant bleeding diathesis due to acquired factor XIII deficiency (2013) (11)
Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia (2020) (11)
Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle Arrest (2020) (11)
Challenges Faced by Prehospital Emergency Physicians Providing Emergency Care to Patients with Advanced Incurable Diseases (2019) (11)
Corrections to "Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines". (2018) (11)
18F]-FDG-PET in clinical stage I and II non-seminomatous germ cell tumors: First results of the German Multicenter Trial (2005) (11)
Hospital population screening reveals overrepresentation of CD5− monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type (2015) (11)
Salvagetherapie rezidivierter und refraktärer Hodentumoren (1998) (11)
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells (2020) (11)
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells (2016) (11)
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. (2009) (11)
High frequency of urothelial cancers in patients with kidney transplantations for end-stage analgesic nephropathy. (1996) (11)
Continuing medical education: a must for every medical oncologist. (2003) (11)
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib. (2009) (11)
Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization. (2015) (11)
Severe aplastic anaemia following leflunomide therapy. (2010) (11)
Incorporation of geriatric assessment into oncology practive: Views and attitudes of physicians participating in the IN-GHO registry. (2011) (11)
Early tumor shrinkage and long-term outcome in metastatic colorectal cancer (mCRC): Assessment of predictive utility across treatment arms in the CRYSTAL and OPUS studies. (2011) (11)
CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA (2012) (11)
Age-related variation and predictors of long-term quality of life in germ cell tumor survivors. (2016) (11)
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia (2020) (11)
Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer (2002) (11)
Safety of catumaxomab: Cytokine-release-related symptoms as a possible predictive factor for efficacy in a pivotal phase II/III trial in malignant ascites. (2009) (10)
Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target? (2013) (10)
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series (2019) (10)
The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus (2016) (10)
Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation (2011) (10)
BRAF V600E Mutation in First-line Metastatic Colorectal Cancer: an Analysis of Individual Patient Data from the ARCAD Database. (2021) (10)
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors (2004) (10)
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II study. (1997) (10)
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study. (2019) (10)
The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia (2016) (10)
Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection (2014) (10)
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells (2004) (10)
Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients (2012) (10)
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors (2007) (10)
Side-effects of GM-CSF treatment in advanced testicular cancer. (1993) (10)
The translocations t(6;18;11)(q24;q21;q21) and t(11;14;18)(q21;q32;q21) lead to a fusion of the API2 and MALT1 genes and occur in MALT lymphomas. (2007) (10)
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3). (2019) (10)
7137 Final analysis of a large open-label, noncomparative, phase 3 study of sorafenib in European patients with advanced RCC (EU-ARCCS) (2009) (10)
Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated “same-day” (< 24 h), “per-guidelines” (24–72 h), and “late” (> 72 h): findings from the MONITOR-GCSF study (2018) (10)
The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature (2020) (10)
Systematic symptom and problem assessment at admission to the palliative care ward – perspectives and prognostic impacts (2020) (9)
Treatment of germ cell tumors--update 2006. (2006) (9)
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors. (2018) (9)
The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna. (1994) (9)
Characterization of Enterobacter cloacae Pneumonia: A Single-Center Retrospective Analysis (2011) (9)
Chemotherapie von Keimzelltumoren (2004) (9)
Chemotherapy plus cetuximab in patients with liver-limited or non-liver-limited KRAS wild-type colorectal metastases: A pooled analysis of the CRYSTAL and OPUS studies (2012) (9)
A novel fusion of the MALT1 gene and the microtubule‐associated protein 4 (MAP4) gene occurs in diffuse large B‐cell lymphoma (2006) (9)
[Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment]. (2003) (9)
Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Interim results of the prospective multicentre noninterventional RECORA study. (2017) (9)
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair (2020) (9)
Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two Cases (2018) (9)
Existential distress in patients with advanced cancer and their caregivers: study protocol of a longitudinal cohort study (2021) (9)
A Phase I/II Study Combining Sunitinib with Standard Ara-C/Daunorubicin Chemotherapy In Patients 60 Years or Older with FLT3 Mutated AML (2010) (9)
Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors. (1997) (9)
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer (2022) (9)
Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor (2010) (9)
The role of high-dose chemotherapy in relapsed germ cell tumors (2004) (9)
The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer. (1992) (9)
Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia (2011) (9)
Pharmacotherapy of relapsed metastatic testicular cancer. (2008) (9)
Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia (2019) (9)
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy. (2020) (9)
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy (2017) (9)
Chemotherapy in Elderly Patients with Advanced Lung Cancer Part II: Treatment of Non-Small Cell Lung Cancer (NSCLC) (2004) (9)
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer (2013) (8)
Treatment of Adult Soft-Tissue Sarcomas with Dose-Intensified Chemotherapy and Haematopoietic Growth Factors (1994) (8)
Proteomic‐based investigations on the mode of action of the marine anticancer compound rhizochalinin (2017) (8)
Single-Center Management of 136 Patients with Cancer of Unknown Primary Site (CUP Syndrome) Over a Period of 10 Years (2009) (8)
First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database (2015) (8)
Evaluation of BM cytomorphology after allo-SCT in patients with AML (2012) (8)
Treatment intensification in disseminated germ-cell tumors (2004) (8)
Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature (2016) (8)
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]. (1995) (8)
New Trisulfated Steroids from the Vietnamese Marine Sponge Halichondria vansoesti and Their PSA Expression and Glucose Uptake Inhibitory Activities (2019) (8)
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]. (2004) (8)
Improved nutrition in adolescents and young adults after childhood cancer - INAYA study (2016) (8)
Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature. (2013) (8)
Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma (2021) (8)
Safe Use of Oxaliplatin in a Patient with Metastatic Breast Cancer and Combined Renal and Hepatic Failure* (2006) (8)
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer (1999) (8)
Diagnosis and Treatment of Patients with Testicular Germ Cell Cancer (1999) (8)
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases. (1998) (8)
Clinical Evidence that Coagulation Activation Drives Cancer Progression - a Report of 2 Cases (2015) (8)
Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group (2009) (8)
Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case report (2009) (8)
53 A phase I study of epidermal growth factor receptor (EGFR) antibody EMD 72000 in combination with paclitaxel (P) in patients (pts) with EGFR-positive advanced non-small cell lung cancer (NSCLC) (2003) (8)
Implementation analysis of patient reported outcomes (PROs) in oncological routine care: an observational study protocol (2020) (8)
Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group (2015) (7)
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. (2018) (7)
Chemotherapy in Elderly Patients with Advanced Lung Cancer. Part I: General Aspects and Treatment of Small Cell Lung Cancer (SCLC) (2004) (7)
First-Line High-Dose Chemotherapy for ’Poor Risk’ Metastatic Non-Seminomatous Testicular Germ Cell Tumors (1998) (7)
[18F]-FDG-PET in germ cell tumors following chemotherapy: Results of the German multicenter trial. (2006) (7)
Aprotinin‐associated hemolytic thrombotic microangiopathy in a patient with acute myelogenous leukemia (AML) and systemic coagulopathy (2007) (7)
Prognostic factors in patients (pts) with advanced metastatic seminoma (SEM) treated with either single agent carboplatin (CP) or cisplatin-based (DDP) combination chemotherapy (CTX): a meta-analysis of prospective European trials. (2002) (7)
Thoughts of death and suicidality among patients with cancer: Examining subtypes and their association with mental disorders (2021) (7)
Antitumor-activity and toxicity of continuous-infusion versus bolus administration of bleomycin in 2 heterotransplanted human testicular cancer cell-lines. (1995) (7)
The influence of gemcitabine on the CD4/CD8 ratio in patients with solid tumours. (1997) (7)
Superior survival after sequential high-dose chemotherapy (HDCT) as compared to single HDCT in patients with relapsed or refractory germ cell tumors (GCT): Six-year long-term follow-up of a prospective, randomized phase II trial. (2011) (7)
Chylothorax in a Patient with Hodgkin's Lymphoma: A Case Report and Review of the Literature (2013) (7)
Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis (2017) (7)
Comprehensive Geriatric Assessment (CGA) in Elderly Patients with Hematological Neoplasia: CGA and Not Age Predicts Mortality - Results from in-GHO®-Registry (2008) (7)
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer. (1999) (7)
Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties (2020) (7)
Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care (2007) (7)
Successful second ITI with factor IX and combined immunosuppressive therapy (2014) (7)
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL. (2020) (7)
Kommentar zum 2016 Positionspapier der Europäischen Gesellschaft für Kardiologie (ESC) zu kardiovaskulären Komplikationen onkologischer Therapien (2018) (7)
Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT (2015) (7)
Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia Blasts (2021) (7)
Activity of gemcitabine in platinum-resistant ovarian germ cell cancer. (1996) (7)
Phase II Evaluation of 5-Fluorouracil plus Folonic Acid and Alpha 2b-lnterferon in Metastatic Colorectal Cancer (1997) (7)
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significance (2015) (7)
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil (2004) (7)
Phantom sensations after orchiectomy for testicular cancer. (1993) (7)
Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML (2013) (7)
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice (2014) (6)
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients—COVIDOUT study (2022) (6)
Gastrointestinal tumors, non-colorectal (2012) (6)
Onkologische Kardiologie (2020) (6)
Management of Invasive Fungal Infections in Oncological Patients (1999) (6)
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer. (2021) (6)
Current Treatment Approaches to Newly Diagnosed Multiple Myeloma (2021) (6)
[18F]FDG-PET, CT/MRT und Tumormarker als prädiktive Indikatoren für das Ansprechen unter Hochdosis-Chemotherapie bei Patienten mit metastasierten Keimzelltumoren (2004) (6)
Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen (2020) (6)
High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers (2019) (6)
Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment (2020) (6)
Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: A systematic review by the Testicular Cancer Guidelines Panel (2018) (6)
Das CARE-for-CAYA-Programm (2017) (6)
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3). (2020) (6)
Das CARE-for-CAYA-Programm. Präventionskonzept für junge Menschen nach Krebserkrankung (2017) (6)
Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells (2020) (6)
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas. (1992) (6)
TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis (2022) (6)
Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature (2016) (6)
Evolving role of cetuximab in the treatment of colorectal cancer (2009) (6)
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study. (1990) (6)
Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts (2004) (6)
Expression and release of platelet protein disulphide isomerase in patients with haemophilia A (2016) (6)
Stadienspezifische Therapie testikulärer Keimzelltumoren (2009) (6)
Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy. (2015) (6)
Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancer (2018) (6)
Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors (2013) (6)
Long term outcome in patients with cisplatin-refractory or multiply relapsed germ cell tumors following treatment with gemcitabine and oxaliplatin {+/-} paclitaxel. (2010) (6)
VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma (2012) (6)
Supportivtherapie bei malignen Erkrankungen (2006) (6)
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support. (2003) (6)
Clinical relevance of germ cell cancer cells detected by real time PCR in apheresis products of poor risk patients undergoing high dose chemotherapy. (2010) (6)
Simultaneous Targeting of Aurora Kinases and Bcr-Abl by the Small Molecule Inhibitor PHA-739358 Is Effective in Imatinib-Resistant Mutations Including T315I. (2007) (6)
A transplant "immunome" screening platform defines a targetable epitope fingerprint of multiple myeloma. (2016) (6)
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer (2023) (6)
Langzeitüberleben bei Krebs: Definitionen, Konzepte und Gestaltungsprinzipien von Survivorship-Programmen (2022) (5)
Pen-based remote data entry system. A pilot clinical trial. (1993) (5)
Impact, challenges and limits of inpatient palliative care consultations – perspectives of requesting and conducting physicians (2020) (5)
Rectal versus left-sided colon cancers: Clinicopathological differences observed in a pooled analysis of 4,182 patients enrolled to 8 clinical trials from the ARCAD database. (2017) (5)
Differences between old (70-80 years) and very old (80+ years) cancer patients: Results from the IN-GHO registry. (2010) (5)
Ototoxicity following therapy for testicular cancer (1993) (5)
Testicular Cancer EAU Guidelines on (2016) (5)
Late Treatment Effects and Cancer Survivor Care in the Young: From Childhood to Early Adulthood (2021) (5)
Elevated pretreatment serum concentration of YKL-40--An independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer (2008) (5)
New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein (2022) (5)
Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature (2016) (5)
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells (2021) (5)
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC). (2007) (5)
Positronenemissionstomographie bei Keimzelltumoren des Mannes (2018) (5)
Acute Megakaryoblastic Leukemia in a Patient with Xeroderma Pigmentosum: Discussion of Pathophysiological, Prognostic, and Toxicological Aspects (2012) (5)
New Aspects for the Diagnosis of Invasive Fungal Disease in Oncological Patients (1997) (5)
Evaluation of BM cytomorphology after allo-SCT in patients with MDS (2013) (5)
Changes in items of a comprehensive geriatric assessment (CGA) during follow-up: Results from the IN-GHO registry. (2014) (5)
New Guidelines on Anaemia Management in Patients with Cancer: How Do These Affect Clinical Practice? (2005) (5)
Development and preliminary psychometric investigation of the German Satisfaction with Comprehensive Cancer Care (SCCC) Questionnaire (2021) (5)
Successful treatment of aTrichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor (1994) (5)
The Impact of Bleeding Disorders on the Socioeconomic Status of Adult Patients. (2018) (5)
SPATTOXIZITAT NACH CHEMOTHERAPIE MALIGNER HODENTUMOREN (1998) (5)
Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer (2008) (5)
Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin (2011) (5)
A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells (2018) (5)
High‐dose chemotherapy in nonseminomatous germ cell cancer (2009) (5)
Multicenter phase II study of irinotecan as second line chemotherapy in metastatic colorectal cancer after prior exposure to infusional 5-FU based chemotherapy (2001) (5)
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors]. (1997) (5)
[Late toxicity after chemotherapy of malignant testicular tumors]. (1998) (5)
Spättoxizität und Survivorship bei Keimzelltumoren (2013) (4)
Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy (2014) (4)
Leptomeningeal metastases: Results of different therapeutic approaches (2007) (4)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts (2017) (4)
Patients with advanced non-seminomatous germ-cell tumour: the art of the start. (2010) (4)
Metabolische Störungen als Notfall bei onkologischen Patienten (1999) (4)
Therapie mit Erythropoetinen in der Onkologie (2003) (4)
Stimulation der Granulopoese mit hämatopoetischen Wachstumsfaktoren (2003) (4)
Need for additional professional psychosocial and spiritual support in patients with advanced diseases in the course of specialist palliative care – a longitudinal observational study (2021) (4)
Sunitinib in patients with multiply relapsed or cisplatin-refractory germ cell cancer: A CUOG/GTCSG cooperative phase II study. (2010) (4)
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies (2021) (4)
Catumaxomab with and without prednisolone in patients with malignant ascites due to epithelial cancer: Results from the phase IIIb CASIMAS study. (2012) (4)
Selinexor, ARA-C and Idarubicin: An Effective and Tolerable Combination in Patients with Relapsed/Refractory AML: A Multicenter Phase II Study (2015) (4)
Activity of lenalidomide in metastatic hepatic epithelioid hemangioendothelioma (HEH): A case report. (2009) (4)
Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer. (1999) (4)
Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer Cells (2022) (4)
Chemotherapie des fortgeschrittenen kolorektalen Karzinoms: Behandlungsoptionen für ältere Patienten (2003) (4)
Comparison of 5 vs 10 μg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer (1993) (4)
Thrombin generation in a patient with an acquired high-titre factor V inhibitor (2015) (4)
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3) (2021) (4)
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation (2021) (4)
Diagnosis, treatment, and use of intravenous iron for chemotherapy-induced anemia in Europe. (2011) (4)
Is There a Need for Pharmacokinetically Guided Carboplatin Dose Schedules (1997) (4)
Effects of a structured counselling-based intervention to improve physical activity behaviour of adolescents and young adult cancer survivors – the randomized phase II Motivate AYA – MAYA trial (2021) (4)
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation. (2020) (4)
Prognostic impact of LDH and HCG levels in marker-positive seminomas. (2020) (4)
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia (2021) (4)
Expression Of Hedgehog Pathway Mediator Gli2 Represents a Clinically Negative Prognostic Marker In Acute Myeloid Leukemia and Its Inhibitor GANT61 Exerts Anti-Leukemic Effects In Vitro (2013) (4)
Corrigendum to: "European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer (2008) (4)
Prognostic value of intracaval neoplastic extension for patients with renal cell cancer (1998) (4)
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas (2013) (4)
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case Study. (2021) (4)
for the recurrence-free and long-term survival of prostate cancer patients (1999) (4)
Current aspects of high-dose chemotherapy in germ-cell tumors. (2003) (4)
Role of Protein Disulfide Isomerase (PDI) In the Expression of Tissue Factor (TF) Procoagulant Activity on Apoptotic Myeloblasts (2010) (4)
Heterogeneity in early lesion changes on treatment as a marker of poor prognosis in patients (pts) with metastatic colorectal cancer (mCRC) treated with first line systemic chemotherapy ± biologic: Findings from 9,092 pts in the ARCAD database. (2017) (4)
A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors. (2002) (4)
Behandlung von Patienten mit cisplatinrefraktären Keimzelltumoren (2003) (4)
Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone (2012) (4)
Chemokine CXCL13 is overexpressed in the tumor tissue and in the peripheral blood of breast cancer patients (2008) (4)
Post-transplant EBV-associated pancreas carcinoma. (1997) (4)
[Stage-specific treatment for testicular germ cell tumours]. (2009) (4)
Prognostic Impact of Physiological B-Cell Precursors (hematogones) in the Bone Marrow As Determined by Immunophenotyping in the Post-Transplant Period in Patients with AML (2012) (4)
Single versus sequential high-dose chemotherapy (HDCT) in patients with relapsed or refractory germ-cell tumors (GCT). (2006) (4)
Adjuvant radiochemotherapy (RTx/CTx) using 5-FU/Folinic acid (FA) /cisplatin (DDP) {+/-} paclitaxel (P) and radiation in patients (pts) with completely (R0) resected high-risk gastric cancer (UICC stages II-IV (M0): An extended phase II study of the AIO/ARO/ACO (2004) (4)
Wirksamkeit und Toxizität der Taxane: Therapie solider Tumoren (2005) (4)
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations]. (2019) (4)
Interdisziplinäre Konsensus-Konferenz zur „Diagnostik und Therapie von Hodentumoren” (1997) (4)
[Treatment of multiple myeloma in elderly patients: consensus of the Geriatric Oncology Working Group of the German Society of Hematologic Oncology and the German Society of Geriatrics]. (2001) (3)
718 SORAFENIB (SOR) DOSAGE PATTERNS IN OLDER PATIENTS (PTS) WITH ADVANCED RENAL CELL CARCINOMA (RCC): A SUBANALYSIS BY AGE OF AN INTEGRATED DATABASE OF 8 COMPANY-SPONSORED CLINICAL TRIALS (2011) (3)
Bilateral metachronous testicular germ cell tumors occurring in two non-twin brothers. Case report and review of the literature. (1995) (3)
Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients (2018) (3)
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years (2022) (3)
EP-1618: Monoubiquitinylated histone H2B as a potential target in treatment resistant germ cell tumors (2018) (3)
Efficacy of antiestrogen treatment in a benign metastasizing leiomyoma with paraneoplastic estradiol production. (1996) (3)
METASTATIC COLORECTAL CANCER: ANALYSIS OF PREDICTIVE UTILITY IN THE CRYSTAL AND OPUS STUDIES (2012) (3)
Nodal, pulmonary and pleural gliomatosis in a 42‐year‐old‐male with non‐seminomatous testicular germ cell cancer (2014) (3)
[Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?]. (2001) (3)
Long-term sorafenib (SOR) safety profile in more than 700 patients (pts) with renal-cell carcinoma (RCC) treated for 12 to 42 months (mos). (2010) (3)
[Chemotherapy for germ cell cancer]. (2004) (3)
Effects of aerobic exercise training on physical performance during myeloablative therapy (2008) (3)
How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence (2022) (3)
[Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis]. (1996) (3)
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM) (2020) (3)
Impact of Disease Evolution on Efficacy Outcomes From Larotrectinib in Patients With Locally Advanced or Metastatic Tropomyosin Receptor Kinase Fusion–Positive Solid Tumors (2021) (3)
Cetuximab plus chemotherapy in patients with liver-limited or non-liver-limited KRAS wild-type colorectal metastases: A pooled analysis of the CRYSTAL and OPUS studies. (2012) (3)
Kras mutations and outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab (2011) (3)
Combination Therapy of Small Molecule Inhibitor PHA-739358 and Tyrosine Kinase Inhibitor Imatinib Yields Synergistic Antiproliferative Effects and Suppresses Emergence of Resistance of Chronic Myeloid Leukemia in Vitro (2008) (3)
Wissen generieren durch Vernetzung von Forschung und Versorgung (2019) (3)
Plasma Tissue Factor (TF) Antigen, Cellular Microparticles and Markers of Coagulation and Platelet Activation in Localized Prostate Cancer. (2005) (3)
Late toxicity after treatment for testicular germ cell cancer (1998) (3)
Kardiotoxizitäten bei Chemo- und Radiotherapie (2009) (3)
Study of Structure–Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents (2022) (3)
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021. (2021) (3)
MicroRNA expression in paternal and cisplatin-resistant germ cell tumor cell lines. (2010) (3)
Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report (2021) (3)
Prospective monitoring of immune signatures in newly diagnosed high risk multiple myeloma patients under treatment with Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd): First results of the GMMG-CONCEPT trial (2019) (3)
1254 Safety and pharmacology of the EpCAM/CD3−bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric or lung cancer (2009) (3)
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): The phase II AVETUX-CRC trial (AIO KRK 0216). (2017) (3)
Late Recurrence of a Pineal Germinoma 14 Years after Radiation and Chemotherapy: A Case Report and Review of the Literature (2013) (3)
[The action and toxicity of taxanes]. (2005) (3)
Phase I trial of SU014813 in patients (pts) with advanced solid malignancies (2007) (3)
Prognosis of stage II and III colon cancer treated with adjuvant 5-fl uorouracil or FOLFIRI in relation to microsatellite status : results of the PETACC-3 trial † (2014) (3)
Survivorship-Programme (2014) (3)
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]. (1998) (3)
5-ht3 antagonist ondansetron for the treatment of chemotherapy-induced nausea and vomiting in an outpatient population. (1994) (3)
Wertigkeit von Proliferationsstatus (PCNA) und p53- Immunhisto-chemie als Prognosefaktor für den klinischen Verlauf superfizieller Harnblasenkarzinome (1995) (3)
A randomised phase II study of gemcitabine versus mitomycin C versus gemcitabine/mitomycin C in patients with advanced pancreatic cancer (2008) (3)
Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48]. (2016) (3)
Studien und personalisierte Medizin in der Onkologie? (2010) (3)
The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature. (2012) (3)
Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel? (2022) (3)
Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study (2010) (3)
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia (2021) (3)
Acquired C 1-inhibitor deficiency with angioedema due to pleomorphic immunocytoma in a patient with three malignant tumors: long-term follow-up data and presentation of an additional case (1996) (3)
Phase II evaluation of 5-fluourouracil plus folinic acid and alpha 2b-interferon in metastatic colorectal cancer. (1997) (3)
Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancer (2004) (3)
Comparison of acetylsalicylic acid and clopidogrel non-responsiveness assessed by light transmittance aggregometry and PFA-100® in patients undergoing neuroendovascular procedures (2020) (3)
No growth-stimulation of heterotransplanted human testicular cancer cell-lines by recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf). (1993) (3)
Self-assessment and Screening for Palliative Care Need in Patients with ChronicHeart Failure (2017) (2)
A randomized trial comparing the toxicity and the treatment costs of HD-VIC plus PBSC transplantation with or without amifostine (AMI) in patients with solid tumors (1999) (2)
Treatment strategies in metastatic testicular cancer. (1993) (2)
Effect of myeloperoxidase on the anticoagulant activity of low molecular weight heparin and rivaroxaban in an in vitro tumor model (2020) (2)
Anaphylactoid Type Reaction in a Patient Receiving High-Dose Methotrexate Chemotherapy (1992) (2)
accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation (2008) (2)
The role of the KRAS G13D mutation in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy plus cetuximab. (2011) (2)
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis (2021) (2)
Therapie von metastasierten Keimzelltumoren bei Patienten mit "Good-prognosis"- Kriterien (2003) (2)
Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP): Results of a multi-center randomized phase II AIO trial. (2019) (2)
Aprepitant as salvage therapy in patients (pts) with chemotherapy (ctx)- induced nausea and emesis (n/v) refractory to prophylaxis with 5-HT3-antagonists and dexamethasone (dexa) (2005) (2)
Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis (2022) (2)
[Tumor vaccines-therapeutic vaccination against cancer]. (2020) (2)
Abstract CT002: BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors (2022) (2)
LBA38 BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours (2022) (2)
Expression of Gli2, a Downstream Mediator of the Activated Hedgehog Pathway, Represents a Negative Prognostic Marker in AML, (2011) (2)
Frequency of chromosomal aneuploidies and deletions of the RB and TP53 genes in MALT lymphomas harboring the t(14;18)(q32;q21). (2006) (2)
104P Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib (2021) (2)
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group. (1994) (2)
Empfehlungen des Arbeitskreises «Supportive Maßnahmen in der Onkologie» zur klinischen Anwendung von Zytoprotektiva (2001) (2)
[Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?]. (1996) (2)
Adjuvant radiochemotherapy (RTx/CTx) using 5-FU/Folinic acid (FA) /cisplatin (DDP) ± paclitaxel (P) and radiation in patients (pts) with completely (R0) resected high-risk gastric cancer (UICC stages II-IV (M0): An extended phase II study of the AIO/ARO/ACO. (2004) (2)
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma (2005) (2)
Erstlinienchemotherapie beim Harnblasenkarzinom (2012) (2)
Noch Fragen? (2013) (2)
Chemotherapie von Keimzelltumoren (2005) (2)
[Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]. (1997) (2)
Treatment of Metastatic Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE) - Long-Term Disease Control by Multimodal Therapy (2018) (2)
Welche Tumorgröße korreliert am besten mit dem Progressionsrisiko lokal organbegrenzter Nierenzellkarzinome (2003) (2)
Expression of Novel Immune Checkpoint Molecules PVR and PVRL2 Confers a Negative Prognosis to Patients with Acute Myeloid Leukemia and Their Blockade Augments T-Cell Mediated Lysis of AML Cells Alone or in Combination with the BiTE® Antibody Construct AMG 330 (2015) (2)
Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer (2019) (2)
[Germ-cell tumors of the testis. The epidemiological and etiological aspects]. (1992) (2)
Biosimilar Filgrastim Initiation in Patients Enrolled in the Monitor G-CSF Observational Study Relative to EORTC Guidelines (2012) (2)
UFT/calcium folinate plus weekly paclitaxel for solid tumors. (1999) (2)
Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk testicular cancer. (1996) (2)
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high‐dose cytarabine and mitoxantrone (2020) (2)
Behandlung des metastasierten Nierenzellkarzinoms (1999) (2)
Long-term effects of testicular cancer treatment on sexual functioning (1997) (2)
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP (2020) (2)
Gonadale Toxizität und Infertilität (2006) (2)
[Clinical trials and personalized medicine in oncology?]. (2010) (2)
Perceived Positive and Negative Life Changes in Testicular Cancer Survivors (2021) (2)
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications. (1995) (2)
Individual specialist physical activity assessment and intervention in advanced cancer patients on a palliative care ward; the 3STEPS-study. (2020) (2)
Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients (2021) (2)
Therapie des fortgeschrittenen nichtseminomatösen Keimzelltumors (1998) (2)
Treatment of Patients with Refractory AML with SU5416 Downregulates VEGF-A, STAT5 and Akt Expression in Leukemic Blasts. (2005) (2)
Follow up after primary treatment: curable diseases treated non-surgically. (2000) (2)
[The synchronous occurrence of acute myeloid leukemia and kidney carcinoma]. (2008) (2)
Is once‐weekly epoetin beta ‘highly effective’ in treating anaemia in patients with lymphoproliferative malignancy? (2004) (2)
Effektivität einer Intervention zur Verbesserung des Ernährungsverhaltens von jungen Patienten nach überstandener Krebserkrankung im Kindes-, Jugend- und jungen Erwachsenenalter (AYAs) mit kardiovaskulärem Risiko – INAYA Studie (2016) (2)
Bevacizumab induces regression of vestibular schwannomas leading to improved hearing in neurofibromatosis type 2 patients (2009) (2)
Phase I study of EMD 525797 (DI17E6), an antibody targeting ανβ integrins, in combination with cetuximab and irinotecan, as a second-line treatment for patients with k-ras wild-type metastatic colorectal cancer. (2012) (2)
[Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors]. (2009) (2)
Assessing palliative care need in left ventricular assist device patients and heart transplant recipients. (2020) (2)
Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients (2020) (2)
Non-Random Pattern of Integration for Epstein-Barr Virus with Preference for Gene-Poor Genomic Chromosomal Regions into the Genome of Burkitt Lymphoma Cell Lines (2022) (2)
Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine (2022) (2)
Tissue Factor (TF) Activation by Antithymocyte Globulin Is Inhibited by a Novel Monoclonal Antibody Specific for Reduced TF Mutated at the Allosteric Cys186-Cys209 Disulfide. (2010) (2)
Symptom burden, psychosocial distress and palliative care needs in heart failure – A cross-sectional explorative pilot study (2022) (2)
PD-0029CHEMOTHERAPY PLUS CETUXIMAB AS CONVERSION TREATMENT FOR PATIENTS WITH INITIALLY UNRESECTABLE LIVER METASTASES FROM COLORECTAL CANCER (2013) (2)
Gender-specific problems and needs of family caregivers during specialist inpatient palliative care: a qualitative study on experiences of family caregivers and healthcare professionals. (2021) (2)
Multicolour banding provides a detailed characterisation of structural abnormalities of chromosome 1 in Burkitt lymphoma (2006) (2)
Expression of Roundabout Receptor 4 (Robo-4) Confers a Negative Prognosis On Patients with Acute Myeloid Leukemia (2012) (2)
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults. (1993) (2)
The use of carboplatin in malignant germ cell tumours. (1994) (2)
Praktische Aspekte der supportiven Therapie in Hämatologie und Onkologie (1998) (2)
Hepatic arterial infusion of the nitrosourea derivate fotemustine for the treatment of liver metastases from colorectal carcinoma. (1997) (2)
N-terminal pro-brain natriuretic peptide (NT-proBNP). (2014) (2)
Therapeutische Ansätze zur Behandlung metastasierter Leydig-Zelltumoren : Seltene urologische Tumoren. II (1994) (2)
The need for microdissectional tumor cell preparation during the molecular genetic analysis of prostate cancer (1999) (2)
Germ cell tumor (GCT): Staging and therapy control with 18FDG-PET. First results of German multicenter trial (1997) (2)
Resistance to Danusertib (formerly PHA-739358) in BCR-ABL-Positive Cells Is Mediated by Upregulation of the Drug Transporter Abcg2 and Can Be Suppressed in Vitro by Combination Treatment with Imatinib. (2009) (2)
The Impact of Bleeding Disorders on the Socioeconomic Status of Adult Patients (2017) (2)
Clinical features of hepatitis E infections in patients with hematologic disorders (2022) (2)
Diagnose und Therapie seltener Hodentumoren am Beispiel des malignen Mesothelioms der Tunica vaginalis testis und Sertoli-Zell-Tumoren (2021) (2)
DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma. (2019) (2)
Evaluation of a program for routine implementation of shared decision-making in cancer care: results of a stepped wedge cluster randomized trial (2021) (2)
[Haemostatic aspects in clinical oncology]. (2008) (2)
MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma (2017) (2)
Maligner gemischter, gonadaler Stromazelltumor des Hodens: Fallbericht über ein interdisziplinäres Management (1993) (2)
The effect of the trifunctional anti-EpCAM antibody catumaxomab on the development of tumor-specific immune responses in patients with gastric cancer. (2011) (2)
Long-Term Survival after Second-Line Therapy with Docetaxel and Carboplatin and Monthly Pamidronic Acid in a Woman with Metastatic Non-Small Cell Lung Cancer (2006) (2)
[Metastatic adult teratoma of the testis. Possibilities of chemotherapy and surgical treatment]. (1994) (2)
Booster vaccination of non-small cell lung cancer (NSCLC) patients with MAGEA3 protein and AS02B adjuvant (2007) (2)
Tipping point: When patients stop eating and drinking in the last phase of their life. (2020) (2)
[Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer]. (2003) (2)
Prognostic and predictive impact of primary tumor sidedness in first-line trials for advanced colorectal cancer: An analysis of 7,828 patients in the ARCAD database. (2020) (2)
Das Zertifizierungssystem der Deutschen Krebsgesellschaft (2021) (2)
Regulation of bone homeostasis by MERTK and TYRO3 (2022) (2)
The role of relative lymphocyte count as a new biomarker for the effect of catumaxomab on overall survival in patients with malignant ascites: Follow-up results from a phase ll/lll study. (2011) (2)
Depth of Response to Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (Isa-KRd) in Front-Line Treatment of High-Risk Multiple Myeloma: Interim Analysis of the GMMG-CONCEPT Trial (2021) (2)
Corrigendum re: "Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours" [Eur Urol 2017;71:213-20]. (2017) (2)
Associated With Primary Mediastinal Nonsemino-matous Germ Cell Tumors (1999) (1)
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study (2021) (1)
Pathobiological Basis of Treatment Strategies of Germ Cell Tumors (2005) (1)
βIII-tubulin overexpression is linked to left-sided tumor localization and nuclear β-catenin expression in colorectal cancer (2015) (1)
[Testicular tumor--yesterday--today--tomorrow]. (2006) (1)
Bone metastases in patients with relapsed/refractory germ cell tumors (GCT) undergoing first salvage chemotherapy: A retrospective analysis of a large international database. (2012) (1)
Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry (2021) (1)
Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer (2022) (1)
P-304RECORA - A national non-interventional study to assess efficacy and safety of regorafenib in patients with metastatic colorectal cancer (mCRC) after failure of standard therapy (2015) (1)
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis (2020) (1)
COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress (2022) (1)
[Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]. (1996) (1)
RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma (2022) (1)
[A multi-disciplinary approach to the treatment of germ cell tumors]. (2010) (1)
How does spirituality manifest in family caregivers of terminally ill cancer patients? A qualitative secondary analysis (2021) (1)
Clinical implications of the p53 tumor-suppressor gene. (1994) (1)
[Current treatment concepts for castration resistant prostate cancer]. (2014) (1)
Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217). (2018) (1)
Molecular- and cytogenetic characterization of the IGH associated t(1;14) in a nodal marginal zone B-cell lymphoma case (2021) (1)
[Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems]. (1995) (1)
1241 POSTER Overexpression of Eukaryotic Initiation Factor 5a (elF-5A) and Hypusine Forming Enzymes in Glioblastoma Patient Samples and Therapeutic Potential of Hypusine Modification for Treatment of Glioblastoma Multiforme (2011) (1)
Non-lymphocytic leukaemia following chemotherapy of a germ cell tumour. (1997) (1)
Catumaxomab versus catumaxomab plus prednisolone in patients with malignant ascites due to epithelial cancer: results from the CASIMAS study (2012) (1)
The prognostic impact of the smoking status of cancer patients receiving systemic treatment, radiation therapy, and surgery: A systematic review and meta-analysis. (2022) (1)
[Registries and clinical trials in geriatric oncology in Germany]. (2009) (1)
Secondary cancer following Hodgkin's disease. (1993) (1)
Evaluation of prognosis in relapsed germ cell tumors: Identification of patients who profit from high dose chemotherapy (HDCT). (2006) (1)
Therapy-Related Leukemia following High-Dose Chemotherapy: Compensating for the Benefit? (2000) (1)
Evaluation of residual or recurrent malignant lymphoma by FDG-PET (1997) (1)
Effects of a structured intervention program to improve physical activity (PA) of adolescents and young adult cancer survivors (AYAs): Final results of the randomized Motivate AYA–MAYA trial. (2019) (1)
Relationship of T lymphocytes, T regulatory cells, and B lymphocytes to clinical outcome in prostate cancer. (2011) (1)
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer (2022) (1)
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data (2023) (1)
New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide (2023) (1)
Two-year follow-up of a phase II study on catumaxomab as part of a multimodal approach in primarily resectable gastric cancer. (2012) (1)
[Chemotherapy of advanced colorectal carcinoma: treatment options for elderly patients]. (2003) (1)
Expression of CEACAM1 in pulmonary adenocarcinoma cells and their metastases. (2006) (1)
Severe Cryoglobulinemic Vasculopathy and Underlying Monoclonal Gammopathy: The Importance of Identifying and Targeting the Underlying Plasma Cell Clone in Diagnosis and Treatment (2021) (1)
Treatment of adult osteosarcoma - single-center results in 47 patients. (1993) (1)
626P Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice: Interim analysis of the non-interventional SCOPE study (2020) (1)
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma (2022) (1)
Supportive Therapie (2002) (1)
Impact of FOLFOXIRI and bevacizumab (bev) compared to FOLFOX and bev on health related quality of life (HRQOL) in patients with metastatic colorectal cancer (MCRC): Analysis of the CHARTA-AIO 0209 trial. (2017) (1)
Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia. (2022) (1)
The Prognostic Role of Alterations of the p53 Tumor Suppressor Gene in Superficial and Advanced Stage Bladder Cancer (1995) (1)
Specific Characteristics of Patients with Advanced Genitourinary Cancer Receiving Specialized Inpatient Palliative Care (2017) (1)
Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database. (2018) (1)
Primary-Tumor-mediated Dormancy of disseminated Breast Cancer Cells in the Bone Marrow due to Down-Regulation of Gas6 (2013) (1)
Geriatric oncology: Appropriate assessment is the basis for clinical trials and routine care. (2003) (1)
Inhibition of Hypusination of Eukaryotic Initiation Factor 5a (eIF-5A) as a Novel a Synergistic Treatment Strategy in Imatinib-Treated BCR-ABL Positive Leukemias Identified by a Global Proteomics Approach. (2005) (1)
[Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas]. (2000) (1)
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG) (2022) (1)
Gremlin-1 Is Overexpressed in Endothelial Cells of Patients with Loeys-Dietz Syndrome Due to Dysregulation of TGF-β Signalling, (2011) (1)
Therapy of clinical stage IIA and IIB seminoma: a systematic review (2021) (1)
A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer (RADIT). (2014) (1)
[Monoclonal Gammopathy Of Unknown Significance - A Common Incidental Finding - What is to be thought of? What has to be done?] (2019) (1)
[Diagnosis and treatment of rare testicular tumors using the example of malignant mesothelioma of the tunica vaginalis testis and Sertoli cell tumors]. (2021) (1)
Donor‐transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation (2022) (1)
Immunohistochemical detection of cathepsin-d expression in prostate-cancer. (1994) (1)
7132 Safety and efficacy of sorafenib in patients with advanced renal cell carcinoma (RCC) with varying histologies: results from the phase 3, open access study of sorafenib in European patients with advanced RCC (EU-ARCCS) (2009) (1)
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience (2022) (1)
228 Adjuvant chemo-radiotherapy with 5FU/FA/DDP/paclitaxel in locally advanced gastric cancer (UICC II–IV M0) (2003) (1)
Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial (2022) (1)
MIS1. colorectal cancer (2012) (1)
Effect of mast cells on efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme b. (2017) (1)
Expression of the cancer-testis antigen FMR1NB on the surface of malignant cells. (2010) (1)
Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis (2021) (1)
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers (2022) (1)
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial (2022) (1)
Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis (2018) (1)
Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID‐19 in a tertiary center – A monocentric analysis (2023) (1)
507PDPOSEIDON PHASE I/II TRIAL: ABITUZUMAB COMBINED WITH CETUXIMAB PLUS IRINOTECAN AS SECOND-LINE TREATMENT FOR PATIENTS WITH KRAS WILD-TYPE METASTATIC COLORECTAL CANCER. (2014) (1)
Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment study. (2013) (1)
Prolonging Survival Through a Personalized Approach in Metastatic Colorectal Cancer (2013) (1)
Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion (2012) (1)
Malignant fibrous histiocytoma of bone - Review of thirteen cases. (1996) (1)
Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors. (1992) (1)
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma (2020) (1)
BGB324 Represents an Axl and BCR-ABL1 Inhibitor with Activity in the T315I Mutant (2014) (1)
Addition of darbepoetin alfa to sequential high-dose VIP chemotherapy for patients with advanced metastatic germ cell cancer. (2012) (1)
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors (2005) (1)
Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias (2021) (1)
Expression of Cancer-Testis Antigens MAGE-C1/CT7 and MAGE-A3 Is Central to the Survival of Myeloma Cells and Their Resistance to Chemotherapy (2008) (1)
Impact of bone metastases at initial diagnosis in male patients with metastatic germ cell tumors: Results from an international database (2014) (1)
Antigen Expression in Multiple Myeloma Longitudinal Analysis and Prognostic Effect of Cancer-Testis (2009) (1)
How to improve toxicity evaluation in clinical trials? Testing new metrics from irinotecan or oxaliplatin-based treatments in metastatic colorectal cancer (mCRC): A pooled analysis from 2,349 patients in ARCAD database. (2020) (1)
Salvage chemotherapy with cisplatin, ifosfamide, and paclitaxel in metastatic castration-resistant prostate cancer. (2021) (1)
Development of a Short Instrument for Measuring Health-Related Quality of Life in Oncological Patients for Clinical Use: Protocol for an Observational Study (2020) (1)
Erratum: Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (Leukemia (2008) vol. 22 (1250-1255) 10.1038/leu.2008.88) (2008) (1)
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines. (2014) (1)
FLT3 - ITD positive acute lymphocytic leukemia, does it impact on disease´s course? (2010) (1)
512PChemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in solid tumours versus haematological malignancies: Patterns, outcomes and determinants (MONITOR-GCSF study) (2017) (1)
Analysis of expression of TGF-β1 receptor (ALK-1) in normal and tumor tissues by tissue microarrays. (2009) (1)
RESPOND - Raising awareness of anemia in oncology centers through computer algorithm driven guidelines: Assessment of intraclass correlation metrics for the accuracy of algorithmic definitions (2007) (1)
907 Endocrinologic late sequelae after chemotherapy for testicular cancer (1995) (1)
Long-Term Follow-Up Guidelines and Organization of Long-Term Follow-Up Care for Childhood and Young Adult Cancer Survivors (2020) (1)
Results from the pilot phase of the IN-GHO registry for elderly cancer patients (2008) (1)
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic (2022) (1)
[Late damage of curative oncologic therapy. Results of a patient sample with Hodgkin's disease and testicular tumors at the Hannover Medical School]. (1996) (1)
Axl Represents a Therapeutic Target In T315I-Mutated and WT Chronic Myeloid Leukemia (2013) (1)
Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA. (2021) (1)
O-0015 Survival According to Prognostic Risk Factors in Patients Receiving First-Line Chemotherapy Plus Cetuximab in the Crystal and Opus Studies (2012) (1)
IS9. colorectal cancer (2012) (1)
Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database. (2022) (1)
[Secondary leukemias after etoposide chemotherapy]. (1994) (1)
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus Penicillium antarcticum KMM 4685 with Potent p-Glycoprotein Inhibitory Activity. (2022) (1)
BCR-ABL Cooperates With a “Telomere-Associated Secretory Phenotype” (TASP) To Facilitate Malignant Proliferation Of Hematopoietic Stem Cells (2013) (1)
849 Multidisciplinary treatment of central nervous system (CNS) metastases in patients with metastatic testicular germ cell tumor (GCT) (2003) (1)
Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial. (2016) (1)
Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib (2019) (1)
Oral Presentations (2016) (1)
FOLFOXIRI plus bevacizumab (BEV) in patients (pts) with previously untreated metastatic colorectal cancer (mCRC): Preliminary safety results from the OPAL study. (2013) (1)
Catumaxomab: Pharmacodynamic and pharmacokinetic data from phase IIIb CASIMAS study in patients with malignant ascites. (2012) (1)
Late onset CMV-disease after allogeneic stem cell transplantation (1996) (1)
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors. (2000) (1)
Evaluation of an electronic psycho-oncological adaptive screening program (EPAS) with immediate patient feedback: findings from a German cluster intervention study (2021) (1)
Erweiterung der Kombinationsmöglichkeiten in der Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms mit Nivolumab plus Cabozantinib (2021) (1)
Erratum zu Onkologie 2000;23:603–613 (2001) (1)
Irinotecan – klinischer Fortschritt in der Second-line-Therapie des fortgeschrittenen Kolorektalkarzinoms (2000) (1)
Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis (2018) (1)
Epoetin alfa zur Behandlung einer Anämie bei Tumorpatienten unter Chemotherapie (2001) (1)
Vorwort (2019) (1)
Hämatopoetische Wachstumsfaktoren (HGF) und Blutprodukte (1998) (1)
Aktueller diagnostischer Standard und Risikostratifizierung der AML (2022) (1)
PROGNOSTISCH RELEVANTE BIOLOGISCHE MARKER FUR DAS NIERENZELLKARZINOM : EINE BESTANDSAUFNAHME (1999) (1)
Begleittherapie bei Ifosfamid und Cyclophosphamid (2006) (1)
Alte Patienten mit akuter myeloischer Leukämie – Charakteristika der Biologie, des Patienten und der Therapie (2003) (1)
Therapie von Hodentumoren : Stadienspezifisch und leitliniengerecht behandeln (TOPIC 1 • therapie von hodentumoren) (2010) (1)
Therapie des fortgeschrittenen Seminoms (1998) (1)
Das P53-Tumorsuppressorgen: Möglicher Prognosefaktor für den klinischen Verlauf von Harnblasenkarzinomen? (1993) (1)
Keimzelltumoren des Mannes (2008) (1)
Der Hodentumor: gestern – heute – morgen (2006) (1)
Therapie des metastasierten Kolonkarzinoms (2009) (1)
Supportivtherapie im Rahmen der Hochdosis-Chemotherapie (2000) (1)
Akute myeloische Leukämie –bestmögliche Behandlung. (2014) (1)
Therapie älterer Patienten mit kolorektalem Karzinom (2002) (1)
Begleittherapie bei Cisplatin (2006) (1)
Monoklonale Gammopathie unklarer Signifikanz – ein häufiger Nebenbefund (2019) (1)
Adjuvante Chemotherapie bei Patienten mit Hochrisikoweichteilsarkomen der Extremitäten (2001) (1)
Rezidivtherapie von Hodentumoren (2009) (1)
Aktuelle Therapieoptionen bei rezidivierter/refraktärer AML (2022) (1)
Thromboembolische Komplikationen – Prophylaxe und Therapie im Fokus (2009) (1)
Behandlung des multiplen Myeloms bei älteren Patienten: Konsensus der Arbeitsgruppe Geriatrische Onkologie der DGHO und DGG (2001) (1)
Cisplatin-refraktäre Keimzelltumoren (2017) (1)
Tumoranämie: Diagnostik, Therapie und Leitlinien (2007) (1)
Induction of apoptosis by flavopiridol (FP) independent of a cell cycle arrest in germ cell tumor (GCT) cell lines. (2004) (0)
P55 Differences and similarities of patients (pts) with solid tumors (ST) and hematologic neoplasias (HN) assessed by Comprehensive Geriatric Assessment (CGA) (2009) (0)
Use of Axl, a therapeutic target in AML, to mediate stroma-induced chemoresistance. (2013) (0)
High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors. (2009) (0)
A Characteristic Cytokine/Chemokine Milieu Is Present in the Bone Marrow Environment of Multiple Myeloma Patients Before and After Allogeneic Stem Cell Transplantation. (2009) (0)
Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Breast Cancer in Women (2016) (0)
Evaluation of a Routine Psychosocial Screening for Patients Receiving Inpatient Specialist Palliative Care: Feasibility and Outcomes (2022) (0)
Therapie der rezidivierten/refraktären akuten myeloischen Leukämie (2023) (0)
Nephrology Dialysis Transplantation Cisplatin nephrotoxicity and protection by silibinin (2005) (0)
Biology of Human Tumors Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors (2014) (0)
Effect of depression, anxiety, and distress screeners on the need, intention, and utilization of psychosocial support services among cancer patients (2023) (0)
A prognostic model for response and outcome in patients with extragonadal germ cell tumors — an international multivariate analysis (2001) (0)
Prognostic factors in metastatic seminomatous germ cell tumours and elevated human chorionic gonadotrophin (HCG): A study of the G3 (2019) (0)
Guidelines EAU Guidelines on Testicular Cancer : 2011 Update (2012) (0)
The tyrosine kinase src plays a crucial role in leukemic cell proliferation in AML (2007) (0)
1596 Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia (CIN/FN) prophylaxis with biosimilar filgrastim and development of an outcomes risk calculator (MONITOR-GCSF study) (2015) (0)
Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis (2023) (0)
LYMPHOID NEOPLASIA A transplant “ immunome ” screening platform de ﬁ nes a targetable epitope ﬁ ngerprint of multiple myeloma (2016) (0)
Phase II study of a combination of radiofrequency ablation (RFA) and systemic chemotherapy for patients with colorectal liver metastases (2005) (0)
Correlation between the presence of lectin binding sites of pulmonary adenocarcinoma cells and their metastatic cells. (2006) (0)
Management of extragonadal seminoma (EG-SEM) — Results of a multicenter analysis of 104 patients (PTS) (1999) (0)
Determination of microvessel density by real-time PCR in esophageal cancer: Correlation with histological methods, angiogenic growth factor expression and lymph node metastasis. (2016) (0)
Longitudinal and Functional Analysis of Spontaneous NY-ESO-1-Specific Antibody Responses in Multiple Myeloma Patients. (2009) (0)
Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Hodgkin ’ s Lymphoma (2016) (0)
A randomized phase III study comparing adjuvant 5-ﬂuorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer (2009) (0)
432P Toxicity and efficacy of 1st line cetuximab (cetux)-based therapy in RAS wildtype (WT) older patients (pts) with metastatic colorectal cancer (mCRC): A pooled analysis from 1,274 pts in the ARCAD database (2020) (0)
Assessing the Need for Palliative Care in LVAD and HTX Patients (2018) (0)
FIRST-LINE CHEMOTHERAPY PLUS CETUXIMAB IN PATIENTS GROUPED ACCORDING TO PROGNOSTIC RISK FACTORS: ANALYSIS OF THE CRYSTAL AND OPUS STUDIES (2012) (0)
Associations of incidence of common adverse events (AEs) and survival outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line chemotherapy: Findings from 9,812 pts in the ARCAD database. (2018) (0)
Treatment effects (TEs) of EGFR monoclonal antibodies (mAbs) in metastatic colorectal cancer (mCRC) patients (pts) with KRAS, NRAS, and BRAF mutation (MT) status: Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database. (2020) (0)
Large retroperitoneal lymphadenopathy (RPLN) and increased risk of venous thromboembolism (VTE) in patients (pts) with metastatic germ cell tumours (mGCT): A Global Germ Cell Cancer Group (G3) Study. (2016) (0)
Chemotherapy for urogenital malignancies (2001) (0)
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma (2020) (0)
B414 Genes MAGE-C1 and MAGE-A3 Are Central to the Survival and Chemotherapy-Resistance of Myeloma Cells (2009) (0)
BCR/ABL status of blood outgrowth endothelial cells from CML patients (2008) (0)
Intermediate prognosis in metastatic germ cell tumors (IPGCT): Outcome and prognostic stratification. (2018) (0)
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells (2017) (0)
Global proteome analysis of germ cell tumor (GCT) cell lines under treatment with cisplatin (CDDP) (2016) (0)
What are the personal last wishes of people with a life-limiting illness? Findings from a longitudinal observational study in specialist palliative care (2022) (0)
Expression of Cancer/Testis Antigens CT10 and SSX in Multiple Myeloma: Promising Targets for Antigen-Specific Immunotherapy. (2005) (0)
The Rare Occurrence of the Translocation t(8;14) in Chronic Lymphatic Leukemia: Case Report and Review of the Literature (2015) (0)
Molecular cytogenetic characterization of chromosome 1 abnormalities in Burkitt's lymphoma (2006) (0)
Differential Effects of Protein Disulfide Isomerase (PDI) Inhibitors On the Expression of Tissue Factor Procoagulant Activity (TF PCA) by AML Blasts (2012) (0)
Sekundärneoplasien nach der Therapie maligner Keimzelltumoren des Hodens (1995) (0)
BMS-262084, a FXIa inhibitor, interferes with tumor cell-induced coagulation activation only in tumor cells with low tissue factor (TF) procoagulant activity (PCA) (2023) (0)
A pilot study of weekly docetaxel and daily trofosfamide as metronomic second-line chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC) (2016) (0)
Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group (2003) (0)
[Passive immunotherapy with monoclonal antibodies]. (2005) (0)
Relationship of YKL-40 protein expression in pulmonary adenocarcinoma and prognosis. (2010) (0)
Management of Anemia in Patients with Hematological Malignancies Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study (2008) (0)
Development of a Short Instrument for Measuring Health-Related Quality of Life in Oncological Patients for Clinical Use: Protocol for an Observational Study (Preprint) (2020) (0)
Venous thromboembolic events stratified by number of risk factors in patients with metastatic germ cell tumours undergoing first-line chemotherapy (2020) (0)
9 Tumorlysesyndrom: Therapie (2012) (0)
The small molecule axl inhibitor BGB324 shows activity against T315I-mutated and BCR-ABL1 wt chronic myeloid leukemia (2014) (0)
9231 An optimized memory B cell assay revealing CT antigen-specific B cells in myeloma patients (2009) (0)
908 Extragonadal germ cell tumours (EGGCT): Experience at Hannover University Medical School (1995) (0)
Expression and Release of Platelet Protein Disulfide (PDI) Isomerase Is Increased in Patients with Hemophilia a (2015) (0)
PD-0030 2-Year Follow-Up of A Phase II Study on Catumaxomab as Part of a Multimodal Approach in Primarily Resectable Gastric Cancer (2012) (0)
Surgical Site Cytology to Diagnose Spinal Lesions (2022) (0)
NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma (2023) (0)
Smoking patterns and the intention to quit in German patients with cancer: study protocol for a cross-sectional observational study (2023) (0)
O-0008ABITUZUMAB COMBINED WITH CETUXIMAB PLUS IRINOTECAN VERSUS CETUXIMAB PLUS IRINOTECAN ALONE, AS SECOND-LINE TREATMENT FOR PATIENTS WITH KRAS WILD-TYPE METASTATIC COLORECTAL CANCER: THE POSEIDON PHASE I/RANDOMIZED PHASE II TRIAL (2014) (0)
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B (2017) (0)
Benefit of prophylactic anticoagulation before and during first-line chemotherapy on patients with metastatic germ cell tumors. (2020) (0)
Multiple Myeloma Patients Treated with Allogeneic Stem Cell Transplantation Show an Increased Frequency of Bone Marrow-Residing CD4 + Foxp3 + T Regulatory Cells. (2006) (0)
Improving care in haemophilia treatment (2009) (0)
Atypical venous thromboses in myeloproliferative neoplasias (2015) (0)
Opposite Effects of Bruton Tyrosine Kinase (BTK) Inhibitor Therapy with Ibrutinib and FCR Chemo-Immunotherapy on the Normal B Lymphocyte Repertoire in Patients with Chronic Lymphocytic Leukemia (2016) (0)
Functional and Antigenic Detection of Intravascular Tissue Factor (TF). (2006) (0)
Onkologie — eine europäische Herausforderung (2012) (0)
Induction of apoptosis and tissue factor (TF) expression in germ cell tumor cell lines by cisplatin chemotherapy (2012) (0)
Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma? (2005) (0)
AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms (2021) (0)
Comparison of three different assays demonstrates heterogeneity in determination of serum free light chains - implications on diagnostic and therapeutic monitoring of multiple myeloma (2019) (0)
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment (2022) (0)
Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors (2009) (0)
452: The Value of Postchemotherapy Surgery in the Management of Patients Harbouring Liver Metatases from Germ Cell Tumors (2006) (0)
9244 Expression and immunogenicity of cancer-testis antigens in acute myeloid leukemia (2009) (0)
522PProof-of-concept of a risk calculator of chemotherapy induced (febrile) neutropenia (CIN/FN) based on real-world evidence (Monitor-GCSF study) (2017) (0)
Continuous 120 hours-infusion (CI) of mitomycin C (MMC) as salvage treatment in progressive or rapidly recurrent gastric cancer (GC) (1997) (0)
Identification of a novel major brekpoint region (MBR) on the MALT1 gene from t(14;18)(q32;q21)/IGH-MALT1-positive MALT lymphomas (2010) (0)
Letters to the editor: Secondary cancer following Hodgkin's disease (1993) (0)
Title Pages / Table of Contents (2011) (0)
High Dose Chemotherapy Plus Stem Cell Support for Poor Risk Testicular Cancer or as Salvage Therapy for Patients with Relapsed Disease (1994) (0)
[Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives]. (2001) (0)
Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database. (2019) (0)
Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’” [European Journal of Cancer 135 (2020) 1-7] (2021) (0)
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies (2021) (0)
In vitro and in vivo investigations of novel 1,4-napthoquinone sulphomethylene carbohydrate conjugates in prostate cancer. (2021) (0)
Abstract 4729: MAGE-C2 promotes proliferation and enhances resistance to p53 DNA damage-mediated apoptosis in multiple myeloma. (2013) (0)
Improved Nutrition in Adolescents and Young Adults after childhood cancer: INAYA-A pilot study. (2016) (0)
Heterogeneity of DNA-damage in ovarian cancer cell lines A2780-WT and multiple drug resistant (mdr) A2780-Dox-5 treated with adriamycin(ADM) (2007) (0)
Chromosomes 2q, 4q and 13q21 Are Preferential Targets of Epstein-Barr Virus (EBV) Integration In Burkitt's Lymphoma Cell Lines (2010) (0)
Author reply (0)
Abstract 2450: Surface molecule CD229 represents a possible target for the treatment of multiple myeloma (2010) (0)
Acute and Late Toxicity on Peripheral Nerves After Chemotherapy — A Review (1995) (0)
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials (2022) (0)
Testicular cancer. (2018) (0)
THE NEED FOR TARGETED THERAPIES TO SUPPRESS THE FORMATION OF MALIGNANT ASCITES Growth of tumors in serous cavities (2009) (0)
Stem Cell Factor und sein Rezeptor c-Kit: Bedeutung für die Keimzellmaturation und die Pathogenese testikulärer Keimzelltumoren (1996) (0)
The role of paclitaxel in the first-line treatment of patients with 'poor prognosis' germ cell tumor (GCT) undergoing sequential high dose chemotherapy. (2004) (0)
Supplementary Material for: Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis (2017) (0)
Identification of Circulating Lymphendothelial Cells in the Blood of Patients with Solid Tumors. (2006) (0)
Testis cancer: some problems still remain unsolved (2017) (0)
FLT3 - ITD positive acute lymphocytic leukemia, does it impact on diseases course? FLT3 - ITD pozitif akut lenfositik lösemi hastal'˙' n' n gidi˝ at' n' etkiliyebilir mi? (2010) (0)
Bone metastases in germ cell tumors: Results from an international data base. (2014) (0)
Exercise-induced immune response in patients with idiopathic pulmonary arterial hypertension (2015) (0)
Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial (2016) (0)
Clinical Study Patients withMultiple Myeloma Develop SOX 2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation (2014) (0)
Taste disorders during chemotherapy (CTX) – TASTE Studie (2018) (0)
ABERRANT SOMATIC HYPERMUTATION IN PRIMARY MED- IASTINAL LARGE B-CELL LYMPHOMA CONTAINS NUCLEAR EXPORT SIGNALS AND REGU- LATES CYTOPLASMIC LOCALIZATION OF BCL10 (2005) (0)
Abstract #1636: Cisplatin resistant germ cell tumors are characterized by microsatellite instability, mismatch repair deficiency and BRAF mutation (2009) (0)
Cancer-Testis Antigen MAGE-C2/CT10 Promotes Proliferation and Enhances Resistance to p53 Mediated Apoptosis in Multiple Myeloma (2012) (0)
for CD30+ Lymphomas Involving the Skin (2007) (0)
[Modern anti-cancer therapy: current state and future developments]. (2014) (0)
Growth promoting factors in human embryomal carcinoma cell lines. (1987) (0)
Bürstner O, et al: De novo malignancies following renal transplantation: Experience of a single center. Onkologie 1995;18:32-38. (1995) (0)
Association between oncologists' death anxiety and their end-of-life communication with advanced cancer patients. (2023) (0)
[Therapy of elderly patients with colorectal carcinoma]. (2002) (0)
P431: THE ROLE OF SMARCA4 IN HEMATOPOIESIS AND ACUTE MYELOID LEUKEMIA (2022) (0)
Unusual Course of Myelodysplastic Syndrome with Presumed Familial Origin (2011) (0)
Comparative proteome analysis of gonadal and extragonadal germ cell tumors. (2006) (0)
Maßnahmen bei Extra- und Paravasation von Zytostatika (1998) (0)
Vorwort: «Targeted therapy in oncology» – von der Forschung zur klinischen Praxis (2005) (0)
Microparticle-Associated Tissue Factor: A Molecular Link Between Coagulation Activation, Inflammation and Disease Progression in Early-Stage Prostate Cancer? (2008) (0)
Evaluation of tumor board recommendations as the center of gastrointestinal oncology (ZGO) at Tübingen University (2003) (0)
Erfolgreiche zweite Immuntoleranzinduktion mit Faktor IX und kombinierter Immunsuppression bei einem Patienten mit schwerer Hämophilie B und Inhibitor-Rezidiv (2014) (0)
Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category (2015) (0)
Translocation t(4;14) Is Not an Adverse Prognostic Factor in Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation. (2007) (0)
A 63-Year-Old Patient with Multicentric Castleman’s Disease and Severe Polyradiculitis (1997) (0)
A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies (2021) (0)
Kongressberichte – Congress Reports (1994) (0)
New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus Penicillium antarcticum KMM 4685 (2023) (0)
[Molecular biology studies of late recurrence of testicular cancers]. (2007) (0)
Editorial Board / Imprint / Innentitel / Contents (2016) (0)
Self-assessment and Screening for Palliative Care Need in Patients with Chronic Heart Failure (2017) (0)
The relative risk of secondary tumors in extragonadal germ cell tumors (EGGCT) (1999) (0)
Update on genitourinary cancers (2006) (0)
S880 A PHASE II STUDY OF SELINEXOR PLUS CYTARABINE AND IDARUBICIN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) (2019) (0)
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors – presentation of the CARE for CAYA-Program study protocol and associated literature review (2020) (0)
Infektiologische Notfälle bei Patienten mit Tumor- erkrankungen (1999) (0)
Gonadal late effects, fertility and sexual functioning in long-term survivors after high-dose chemotherapy with autologous stem cell transplantation (HD-CT) for testicular cancer. (2004) (0)
Comparison of combination treatment with endostatin, soluble neuropilin-1 and thrombospondin-2 to single inhibitors in antiangiogenic therapy of renal cell carcinoma (2016) (0)
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-£uorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer (2002) (0)
UFT/LV in heavily pretreated patients (2003) (0)
Molecular profiling of testicular cancer. (2014) (0)
Molecular Characterization of the T(14;18)(q32;q21) Involving the IGH Locus and the MALT1 Gene in MALT Lymphomas (2008) (0)
Treatment and Survival Outcomes by Age Following Second-Line Therapy for Metastatic CRC (mCRC): Analysis of 13,149 Patients from the ARCAD Clinical Trials Program (2021) (0)
Vorwort (2018) (0)
Extramedullary Plasmacytoma of the Lung - Rather a Disseminated than a Localized Disease? - A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread (2012) (0)
Integrative public data-mining pipeline for the validation of novel independent prognostic biomarkers for lung adenocarcinoma. (2020) (0)
[New Aspects in Treatment of Metastatic Prostate Cancer]. (2017) (0)
New Guanidine Alkaloids Batzelladines O and P from the Marine Sponge Monanchora pulchra Induce Apoptosis and Autophagy in Prostate Cancer Cells (2022) (0)
Metastatic Bone Marrow Involvement in Malignant Germ Cell Tumors (1992) (0)
This letter was referred to the authors, who respond as follows: (1998) (0)
VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma (2012) (0)
Contents Vol. 126, 2011 (2011) (0)
An exploratory analysis of transfusion risk when initiating darbepoetin alfa (DA) therapy at baseline hemoglobin (Hb) < 9 g/dl vs 9 to < 10 g/dl versus ≥ 10 g/dl in patients (pts) with chemotherapy-induced anemia (CIA). (2010) (0)
713 The PRAME opportunity – high peptide copy numbers, homogenous expression and high prevalence to address a broad patient population across different solid cancers with TCR-based therapeutics (2022) (0)
The clonality of immunoglobulin repertoire in prostate cancer-infiltrating B cells. (2012) (0)
Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome (2021) (0)
P3-05-05: Cyclin D1 Gene Amplification Is Rarely Heterogeneous in Breast Cancer. (2011) (0)
Gender differences in comprehensive geriatric assessment (CGA): Results from the IN-GHO registry. (2013) (0)
Cytostatic drugs (1984) (0)
416 Cancer-testis Antigen MAGE-C2/CT10 Promotes Proliferation and Resistance to Apoptosis in Multiple Myeloma (2012) (0)
Amlfostine protects against acute clsplatin/ifosfamide-induced kidney damage assessed by measurement of glomerular and tubular enzymes (1997) (0)
Mechanisms of Platelet Activation by Antithymocyte Globulin (ATG). (2006) (0)
6515 POSTER Application of the Trifunctional Antibody Catumaxomab as Part of a Multimodal Approach in Resectable Gastric Cancer is Feasible and Promotes the Development of Tumour-specific Immune Responses (2011) (0)
Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT) (2007) (0)
Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Aplastic Anemia-Diagnos tics and Therapy of Acquired Aplastic Anemia (2016) (0)
No Beyer et al consensus Ann Oncol 2012 (2012) (0)
Analysis of 94 patients with advanced biliary tract cancer (2007) (0)
Management of Anemia in Multiple Myeloma Patients Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study (2008) (0)
Contents, Vol. 20, 1997 (1997) (0)
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study (2021) (0)
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer (2022) (0)
Treatment of Patients with Stage II A/B and Advanced Nonseminomatous Germ Cell Tumors (2011) (0)
Chemotherapy Plus Cetuximab in Patients with Colorectal Metastases Grouped by Site: A Pooled Analysis of the Crystal and OPUS Studies (2012) (0)
Efficacy and safety of gemcitabine, oxaliplatin and paclitaxel (GOP) in cisplatin-refractory germ cell tumors in routine care: Registry data from an outcomes research project. (2015) (0)
Das nicht-kleinzellige Lungenkarzinom – Status Quo 2012 (2013) (0)
Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines (2004) (0)
256: Plasma Tissue Factor (TF) Antigen, Cellular Microparticles, and Markers of Coagulation and Platelet Activation in Localized Prostate Cancer (2006) (0)
1INADVANCES IN THE TREATMENT OF METASTATIC GERM CELL CANCER AND COLORECTAL CANCER IN RECENT YEARS. (2014) (0)
Intermediate prognosis in metastatic germ cell tumors (IPGCT): Outcome and prognostic factors. (2017) (0)
Thyroid toxicity after treatment of Hodgkin's disease (1997) (0)
Improved nutrition in adolescents and young adults after childhood cancer - INAYA study (2016) (0)
The Tyrosine Kinase src Is Highly Activated in AML and Plays a Crucial Role in Leukemic Cell Proliferation. (2005) (0)
This is a repository copy of Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B (2019) (0)
Patterns of relapse after primary or salvage high-dose chemotherapy in patients with advanced nonseminomatous germ cell tumors (2008) (0)
Analysis of four human PlGF isoforms and of VEGFR-1 in esophageal carcinoma. (2010) (0)
Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling (2020) (0)
813PDBRAIN METASTASES IN MALE GERM CELL TUMORS (GCT): A LARGE RETROSPECTIVE ANALYSIS ON BEHALF OF THE SWENOTECA AND THE G3 CONSORTIUM. (2014) (0)
Axl, a therapeutic target in AML mediates stroma-induced chemoresistance (2013) (0)
Anemia in cancer (2015) (0)
Title Page / Table of Contents (2009) (0)
Abstract 1161: COX-2 blockade improves efficacy of VEGF-targeting drugs (2014) (0)
BMS-354825 (BMS) inhibits the kinase activity of mutant KIT proteins associated with seminomas (S) and has synergistic effects with cisplatin (CDDP) (2005) (0)
Catumaxomab as part of a multimodal approach in primarily resectable gastric cancer: 2-year follow-up of a phase II study (2012) (0)
Longitudinal Analysis of Cancer-Testis Antigen Expression in Multiple Myeloma. (2007) (0)
RESEARCH PAPER Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer (2010) (0)
15th Annual Meetings: Association for Oncology of the Upper Rhine (AOR) (1998) (0)
M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines (2014) (0)
Prognostic factors for the efficacy of catumaxomab in patients (pts) with malignant ascites (MA): Meta-analysis from two phase III studies. (2013) (0)
Paraneoplastic Syndromes of the Hematopoietic System (1998) (0)
Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN) (2018) (0)
Adjuvante Therapie des Kolonkarzinoms (2009) (0)
Looking back: Identifying supportive care and unmet needs of parents of children receiving specialist paediatric palliative care from the bereavement perspective (2022) (0)
Detection of circulating lymphendothelial cells in patients with solid tumors. (2006) (0)
FMR1NB represents a highly specific surface antigen in patients with acute myeloid leukemia (2010) (0)
Abstract 789: Cytokine interleukin-16 is an important growth-promoting factor for multiple myeloma (2011) (0)
Clinical Outcome of Topotecan: New Strategies Play an Important Role in the Treatment of Lung Cancer, Other Solid Tumors, and Hemoblastosis (1998) (0)
First-line chemotherapy plus cetuximab in patients grouped according to prognostic risk factors: Analysis of the CRYSTAL and OPUS studies. (2012) (0)
Neue Aspekte in der Therapie des metastasierten Prostatakarzinoms (2017) (0)
Strong Antibody Responses Against a Unique Region of CT-Antigen SSX-2 Are Induced After Allogeneic Stem Cell Transplantation and Correlate with Clinical Remission In Patients with Multiple Myeloma (2010) (0)
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment (2022) (0)
Large retroperitoneal lymphadenopathy (RPLN) and increased risk of venous thromboembolism (VTE) in patients (pts) with metastatic germ cell tumours (mGCT): a global germ cell cancer group (G3) study (2016) (0)
Multi tyrosine kinase inhibitor dasatinib as novel cause of pulmonary artery hypertension ? (2010) (0)
Contents · Inhalt / Editorial (2000) (0)
Immunophenotyping of tumor-infiltrating T cells in primary CNS lymphoma (2021) (0)
14th Annual Meeting Oberrheinische Arbeitsgemeinschaft für Onkologie (OAO). Groupe de Travail des Oncologues du Rhin Supérieur (GTOR), Metz, February 6–7, 1998 (1997) (0)
Longitudinale Untersuchung der Expression von Cancer/Testis-Antigenen im Knochenmark von Patienten mit Multiplem Myelom (2010) (0)
AR-V7 scheint prädiktiv für Resistenz gegen antiandrogene Therapie (2015) (0)
[CARD study: relevance for the treatment of advanced prostate cancer]. (2020) (0)
519PFOLFOXIRI + BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC): FINAL SURVIVAL AND PHARMACOGENOMIC PROFILING RESULTS FROM THE OPAL STUDY. (2014) (0)
[Is adrenalectomy an indispensable part of nephrectomy? Results of a multivariate statistical analysis]. (2003) (0)
CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients (2021) (0)
Trials in progress: The influence of the therapy sequence in patients with metastatic castration resistant prostate cancer (mCRPC) treated with Cabazitaxel - the international, prospective non-interventional trial SCOPE (2015) (0)
Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct) (2007) (0)
First-salvage treatment in patients with recurrent or refractory advanced germ-cell cancer after cisplatin-based chemotherapy: A database of the German Testicular Cancer Study Group. (2013) (0)
Evaluating longitudinal toxicity of cetuximab in patients with metastatic colorectal cancer (mCRC): A pooled analysis from 1,302 patients in the ARCAD database. (2021) (0)
9238 POSTER Allogeneic Stem Cell Transplantation Induces Autoantibodies Against Cancer Testis Antigens in Multiple Myeloma Patients (2011) (0)
9230 Allogeneic stem cell transplantation induces high-titered antibody responses to cancer testis antigens in multiple myeloma patients (2009) (0)
P.17 First results from the pilot phase of the IN-GHO® registry for elderly cancer patients (2007) (0)
Primary Osteogenic Sarcoma of the Breast: Report of a Case and a Short Review of the Literature (1995) (0)
New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer (1999) (0)
Correction to: Evaluation of an electronic psycho-oncological adaptive screening program (EPAS) with immediate patient feedback: findings from a German cluster intervention study (2021) (0)
Contents Vol. 32, 2009 (2009) (0)
Mutationsanalysen des VEGFRezeptors 2 und des FLT3 Rezeptors bei verschiedenen Tumorentitäten (2011) (0)
Relapse-free and overall survival in patients with non-seminomatous testicular germ cell tumours with teratoma-free primaries. (2023) (0)
Nonseminomatous Testicular Cancers in Clinical Stage IIA/B: Primary Chemotherapy or Primary Lymphadenectomy? (1998) (0)
P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL (2022) (0)
Trajectories of body weight change and survival among mCRC patients treated with systemic therapy: Pooled analysis from the ARCAD database. (2022) (0)
TEMPORARY REMOVAL: PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression. (2022) (0)
Increased Frequency of TOX+ CD39+ TIGIT+ CD73- CD8+ T Cells in Patients with Newly Diagnosed AML (2020) (0)
[55-year old woman, smoking, with obvious exhaustion, fever and hemopysis]. (2014) (0)
[Increasing combination possibilities for first-line treatment of metastatic clear cell renal cell carcinoma with nivolumab plus cabozantinib]. (2021) (0)
International Journal for Cancer Research and Treatment (2016) (0)
No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation. (2006) (0)
Expression der Aspartylprotease Kathepsin D an Prostatakarzinomen und benigner Prostatahyperplasie (1995) (0)
II. Medizinische Klinik und Poliklinik - Onkologie, Hämatologie, Knochenmarktransplantation mit der Sektion Pneumologie (2013) (0)
Cetuximab: Auf dem Weg zur individualisierten Erstlinientherapie (2008) (0)
6th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 6 (1998) (0)
P16.06 Immunophenotyping of tumor-infiltrating T cells in primary CNS lymphoma (2021) (0)
Stellenwert der Hochdosischemotherapie (HDCT) beim männlichen Keimzelltumor (2013) (0)
Rolle der systemischen Therapie ± Radiotherapie beim resektablen Kardia-/Magenkarzinom (2005) (0)
10 Tumorlysesyndrom - Prophylaxe und Therapie: Prophylaxe (2008) (0)
Prophylaxe und Therapie venöser Thromboembolien bei Patienten mit Malignomen (1998) (0)
Möglichkeiten der palliativen Therapie des Rektumkarzinoms (2005) (0)
Geriatrische Onkologie - Zu alt für eine Chemotherapie? (2005) (0)
Wenn Angehörigen die Kraft ausgeht: Wie erleben und begleiten Mitarbeitende der Hospiz- und Palliativversorgung Angehörige in akuten Überforderungssituationen? [256] (2020) (0)
Molekularbiologische Untersuchungen des Spätrezidivs bei Hodentumoren (2007) (0)
The old cancer patient. (2001) (0)
Gobal DNA methylation in fetal human germ cells and germ cell tumors: correlation with differentiation and cisplatin resistance (2010) (0)
DNA-Reparaturdefekte und Olaparib (2016) (0)
Antiemetische Therapie (2003) (0)
Demoralisierung, Hoffnungslosigkeit, Depression und Angst bei unheilbar kranken Krebspatienten auf einer Palliativstation (2014) (0)
EXTREME-Studie definiert neue Referenztherapie mit Cetuximab (2008) (0)
Häufigkeit von Alterationen des P53-Tumor-suppressorgens an Nierenzellkarzinomen und Korrelation mit dem klinischen Stadium (1995) (0)
Molekulargenetische Diagnostik - Was wissen die Maschinen? Was wollen wir wissen?: DGHO-Frühjahrstagung 2016, Berlin, April 2016 (2016) (0)
Register und Studienaktivitäten in der Geriatrischen Onkologie (2009) (0)
Renale Toxizität antineoplastischer Substanzen (2021) (0)
Therapie der akuten Promyelozytenleukämie (2022) (0)
9 Tumorlysesyndrom: Diagnostik (2012) (0)
FDG-PET: Beeinflussung des therapeutischen Managements onkologischer Patienten (2002) (0)
Cisplatinrefraktäre Keimzelltumoren – molekulare Grundlagen und klinische Konzepte (2020) (0)
Ist die Adrenalektomie unverzichtbarer Bestandteil der Tumornephrektomie? (2003) (0)
Harnblasenkarzinom: Aktuelle und künftige Behandlungskonzepte (2019) (0)
Therapie metastasierter Keimzelltumoren des Hodens (2000) (0)
Band 22, Heft 3, Juni 1999 (1999) (0)
Neoglykoprotein-gesteuertes Drug-Targeting für embryonale Karzinomzellinien (1988) (0)
An individual patient data (IPD) prognostic factor study on the value of pathological factors in clinical stage I seminoma testis patients under active surveillance from the EAU Testicular Cancer Guidelines panel (2020) (0)
Therapie von Hodentumoren (2010) (0)
31. Deutscher Krebskongress – Aktuelle Entwicklungen und Diskussionen in der Uroonkologie (2014) (0)
Chemotherapie und systemische Therapie bei Lebermetastasen (2010) (0)
Empirical Vs. Prophylactic Antifungal Strategies: Comparison of Effectiveness In High Risk AML Patients at a Tertiary Cancer Center (2010) (0)
Die Tumorhistologie als prädiktiver Faktor in der NSCLC-Therapie (2008) (0)
Störung der Leydigzellfunktion nach zytotoxischer Chemotherapie (1999) (0)
Treatment and mortality rates of older cancer patients with a body mass index <20: Results from the IN-GHO registry. (2012) (0)
Pamidronat zur Prävention osseärer Ereignisse (2000) (0)
Mitteilungen onkologischer Gesellschaften Reports of Oncological Societies (2010) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Diagnostik (ovarielle Marker, Spermiogramm) (2013) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Spezielle Patientenkollektive (2013) (0)
Das metastasierte adulte Teratom des Hodens. Therapeutische Möglichkeiten : Seltene urologische Tumoren. II (1994) (0)
Wie manifestiert sich Spiritualität bei Angehörigen von Patienten in der Palliativversorgung? Eine qualitative Sekundäranalyse [336] (2020) (0)
Prognostische Bedeutung der zellzyklusassoziierten Gene p27Kip 1 und p21WAF/Cip für das muskelinvasive Harnblasenkarzinom (1998) (0)
Abstract 5383: Cucurbitacin B, a novelin vivopotentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer (2010) (0)
Chemotherapie metastasierter Keimzelltumoren des Hodens (2000) (0)
Metastasiertes Nierenzellkarzinom: zytoreduktive Nephrektomie obsolet? (2018) (0)
Venöse thrombembolische Komplikationen bei Patienten mit fortgeschrittenem Keimzelltumor unter Platin-basierter Chemotherapie - Inzidenz und Risikofaktoren (2013) (0)
Bahnbrechende Daten aus der Uroonkologie (2017) (0)
Inhalt Band 32, 2009 (2009) (0)
Sachwortverzeichnis Band 32, 2009 (2009) (0)
Alteration of thep53Tumor Suppressor Gene in Prostate Cancer: Analytical Approaches and Clinical Implications (1998) (0)
PROGNOSTISCHE RELEVANZ DES KAVATHROMBUS BEIM NIERENZELLKARZINOM (1998) (0)
Passive Immuntherapie mit monoklonalen Antikörpern (2005) (0)
Impact of overall severity of adverse events (AEs) on long-term outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line systemic chemotherapy: Findings from 3,971 pts in the ARCAD database. (2017) (0)
Ist die zytoreduktive Nephrektomie beim mRCC noch Standard? (2019) (0)
Identification of prognostic subgroups in patients (PTS) with poor risk germ cell cancer (GCT): a cart analysis (1999) (0)
Versuch einer Risikostratifizierung für thrombembolische Komplikationen bei Tumorpatienten (2006) (0)
10 Tumorlysesyndrom - Prophylaxe und Therapie: Diagnostik (2008) (0)
Analyse von 94 Patienten mit einem fortgeschrittene n Gallengangs- oder Gallenblasenkarzinom in Bezug auf klinische Charakteristika, therapeutische Strategien sowie prognostische Faktoren (2008) (0)
Rezidivtherapie und Prognosefaktoren im Rezidiv bei Hodentumoren (2008) (0)
Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia (2011) (0)
Verminderung der zytostatikaassoziierten Toxizität bei älteren Patienten (1998) (0)
Familiäre Konflikte und schwierige Familiendynamiken am Lebensende: Eine versorgungsrelevante Belastung für Mitarbeitende hospizlich-palliativer Einrichtungen [339] (2020) (0)
9 Tumorlysesyndrom: Ursachen und Pathophysiologie (2012) (0)
Immun-Chemotherapie bei metastasiertem Nierenzellkarzinom (1999) (0)
Rekombinantes Erythropoetin bei hämatologischen Neoplasien (2004) (0)
Angehörige(r) sein – Ressourcen stärken: Eine Schulungs- und Informationsreihe für Angehörige schwerkranker Patienten [250] (2020) (0)
Abstract 3253: Mast cell-derived granzyme b contributes to resistance against anti-angiogenic therapy (2016) (0)
Registerstudie für die Behandlung von Hirnmetastasen maligner Hodentumoren (1998) (0)
9 Tumorlysesyndrom: Prophylaxe (2012) (0)
Band 25, Heft 1, Februar 2002 (2002) (0)
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217) (2020) (0)
9 Tumorlysesyndrom - Prophylaxe und Therapie: Definition, Problembeschreibung und Epidemiologie (2012) (0)
Bedeutung der lokalen und systemischen Hämostaseaktivierung für die Versorgung krebskranker Patienten (2010) (0)
Phase II study of 24 hours-infusion of 5-fluorouracil and high dose folinic acid in patients with progressive or recurrent colorectal cancer (CRC) (1997) (0)
Der Stellenwert der Positronen-Emissions-Tomographie (18 F- FDG-PET) in Diagnostik und Therapiekontrolle bei Hodgkin- Lymphomen (2011) (0)
Harnblasenkarzinom: Der vergessene Tumor (2012) (0)
Proximale Ulnaris- und Medianusparese als Folge eines traumatischen Aneurysmas der Arteria brachialis (1990) (0)
Sachwortverzeichnis Band 20, 1997 (1997) (0)
Deutsche, sterreichische und Schweizerische Gesellschaften fr Hmatologie und Medizinische Onkologie: Gemeinsame Jahrestagung, Hamburg, Oktober 2014: Abstracts (2014) (0)
Das metastasierte adulte Tetatom des Hodens. Möglichkeiten der chemotherapeutischen und operativen Behandlung (1994) (0)
10 Tumorlysesyndrom - Prophylaxe und Therapie: Literatur (2008) (0)
Mandarin Translations (2010) (0)
Symptome komplizierter Trauer, posttraumatischer Belastung und Depression bei Angehörigen nach Versterben eines nahestehenden Menschen auf einer Palliativstation [253] (2020) (0)
Interdisziplinäres Symposium der Arbeitsgemeinschaft Radiologische Onkologie (ARO) der Deutschen Krebsgesellschaft e.V., gemeinsam mit anderen Arbeitsgemeinschaften, der Sektion Radio-Onkologie der Deutschen Röntgengesellschaft e.V., der Bayerischen Röntgengesellschaft e.V. und dem Tumorzentrum Erla (1993) (0)
Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells (2020) (0)
Abstract 515: Generation of MAGE-C2/CT10-specific T cell clones for immunotherapy of multiple myeloma (2012) (0)
Kapazität der onkologischen Versorgung in deutschen onkologischen Spitzenzentren während der ersten 2 Jahre der COVID-19-Pandemie (2022) (0)
Chemotherapie des metastasierten Blasenkarzinoms (2001) (0)
Der G-Protein gekoppelte Rezeptor GPRC5A ist ein prognostischer Faktor bei nicht-kleinzelligen Bronchialkarzinomen (2012) (0)
Einfluss des Tyrosinkinase-Inhibitors Imatinib auf das ErbB3- Receptor Binding Protein1 (Ebp1) in der CML (2014) (0)
Erfolgreiche Eradikation eines Faktor-VIII-Inhibitors bei einem 60-jährigen Patienten mit milder Hämophilie A mit Prednisolon (2012) (0)
Nutzung von Maßnahmen zur Brustkrebsfrüherkennung und Veränderungen in der Behandlung von Wechseljahresbeschwerden bei Hamburger Frauen im mittleren bis höheren Lebensalter (2014) (0)
Untersuchungen zur Interaktion von CLL B-Zell-Rezeptoren mit Autoantigenen (2013) (0)
Vorwort (2016) (0)
Congress Report – Kongreßbericht (1997) (0)
Therapy of Solid Tumors: Efficiency and Toxicity of Taxanes (2005) (0)
„Orales 5-FU (Capecitabin) ist in der adjuvanten Therapie genauso effektiv wie die Gabe von 5-FU als i.v. Therapie, aber weniger nebenwirkungsreich”: Neue Therapiestrategien beim kolorektalen Karzinom (2004) (0)
Schaden oder Nutzen einer Therapie mit Erythropoietin? (2004) (0)
10 Jahre Arbeitsgruppe Geriatrische Onkologie der DGHO/DGG/AIO (2009) (0)
Primär mediastinale Keimzelltumoren – eine interdisziplinäre Herausforderung (2020) (0)
Behandlung der tumorinduzierten Hyperkalzämie und össärer Filiae (1998) (0)
Embryonales Rhabdomyosarkom der Prostata (2008) (0)
Entwicklung antiangiogener Kombinationstherapien zur Behandlung des Nierenzellkarzinoms (2007) (0)
Abstract (1984) (0)
Adjuvante Chemotherapie beim komplett resezierten nicht kleinzelligen Lungenkarzinom (2008) (0)
Predictive I mpact o f 2 - 18 Fluoro-2-Deoxy-D -Glucose Positron E mission T omography f or R esidual Postchemotherapy M asses i n P atients W ith B ulky Seminoma (2001) (0)
Die akute Promyelozytenleukämie - ein hämatologischer Notfall (2022) (0)
Bevacizumab – der neue Standard in der Darmkrebstherapie (2008) (0)
Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanisms (2022) (0)
Hodentumoren (2021) (0)
Perioperative Systemtherapie des muskelinvasiven Harnblasenkarzinoms (2019) (0)
Subject Index Vol. 20, 1997 (1997) (0)
Lieferengpässe von Onkologika: Die gesicherte Versorgung ist ethische Verpflichtung (2016) (0)
Gezielte Früherkennung und risikoadaptierte Therapie (2019) (0)
Stellenwert von Cabazitaxel in der Therapiesequenz des kastrationsresistenten Prostatakarzinoms gefestigt – die CARD-Studie (2020) (0)
Lokal-ablative Radiotherapie des oligometastasierten Prostatakarzinoms mit Überlebensvorteil (2019) (0)
Begleittherapie bei Methotrexat (2021) (0)
Teratogenität und Mutagenität (2006) (0)
Vorspann (1997) (0)
Wilsede Schule für Onkologie und Hämatologie (1992) (0)
Rolle der Hochdosischemotherapie bei metastasierten oder rezidivierten Keimzelltumoren männlicher Patienten (2017) (0)
Wachstumsstimulierende Faktoren humaner embryonaler Karzinomzellinien: In vitro-Untersuchungen (1988) (0)
Adjuvante Radiochemotherapie (RTx/CTx) mit 5-FU/Folinsäure (FS)/Cisplatin (CDDP)/Paclitaxel (P) bei Patienten mit R0-Resektion bei High-risk-Magencarcinom (UICC-Stadien II-IV[M0]) (2003) (0)
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer (2020) (0)
Neuer Tyrosinkinaseinhibitor für die Zweitlinie (2017) (0)
Systemische Behandlung des Harnblasenkarzinoms (2017) (0)
Behandlung von Patienten mit metastasierten Keimzelltumoren (2008) (0)
Systemtherapie bei metastasierten Keimzelltumoren des Hodens (2021) (0)
Behandlung von Patienten mit cisplatinrefraktären Keimzelltumoren (2003) (0)
Cabazitaxel under routine conditions for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC): Interim results of the non-interventional SCOPE study. (2018) (0)
Klinisch relevante Blutungsneigung infolge eines erworbenen Faktor XIII-Mangels (2013) (0)
Multikinasehemmer Sorafenib: Verlängertes Überleben beim Nieren- und beim Leberkrebs (2008) (0)
Supportive Therapie und Begleitmaßnahmen beim Einsatz von Zytostatika (2005) (0)
The Situation of Elderly Cancer Patients (2001) (0)
Pharmakokinetische Parameter (2013) (0)
Germ-cell tumors. (2007) (0)
Band 23, Heft 5, Oktober 2000 (2000) (0)
Urogenitale Malignome: Active Surveillance auch beim Seminom (2013) (0)
Wilsede-Schule für Onkologie und Hämatologie: Rückblick auf die Jahre 1989–1999 (2000) (0)
Stellenwert der Hochdosischemotherapie bei malignen Keimzelltumoren (2007) (0)
PD-1-Blockade zeigt therapeutische Aktivität (2015) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Präventive Strategien zur Vermeidung der Infertilität bei antineoplastischer Therapie (2013) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Empfehlungen zur Beratung von Patienten (2013) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Menopausale Beschwerden und Hormonersatztherapie (2013) (0)
Studien zum Kolorektalkarzinom (2006) (0)
Band 24, Heft 1, Februar 2001 (2001) (0)
Symptombelastung bei Palliativpatienten – Perspektive des Patienten, der Angehörigen und der behandelnden Ärzte (2012) (0)
Treatment of non-resectable carcinoid liver metastasis with interferone alppha 2B (1993) (0)
Untersuchung der möglichen Rolle von zirkulierenden vaskulären und lymphatischen Endothelzellen, sowie zirkulierenden Tumorzellen im Blut als Surrogatmarker für die klinische Wirkung bei der antiangiogenetischen Therapie mit SU014813 (2009) (0)
Schwere PAH unter der Therapie mit zwei Multityrosinkinase-Inhibitoren Imatinib und Dasatinib – Fallbericht (2009) (0)
10 Tumorlysesyndrom - Prophylaxe und Therapie: Therapie (2008) (0)
Integration von palliativmedizinischer Betreuung – Ist früher besser? (2015) (0)
Implementierung einer Palliativeinheit auf einer onkologischen Normalstation (2008) (0)
Refraktäre Keimzelltumoren (2008) (0)
‘Erythropoietin’Besser leben! – Länger leben? Symposium und Podiumsdiskussion. 28. April 2001, Curiohaus, Hamburg (2001) (0)
Aktuelle Therapiekonzepte bei Keimzelltumoren des Mannes (2021) (0)
MOLEKULARBIOLOGISCHE ANALYSE DER WIRKUNG DES ANGIOGENESEINHIBITORS SU6668 ALS SECOND -LINE THERAPIE IM RAHMEN EINER STUDIE BEI PATIENTEN MIT MULTIPLEM MYELOM (2006) (0)
10 Tumorlysesyndrom - Prophylaxe und Therapie: Ursachen und Pathophysiologie (2008) (0)
und Infertilität durch antineoplastische Substanzen (2020) (0)
Kastrationsresistentes fortgeschrittenes Prostatakarzinom: Viele innovative Substanzen (2015) (0)
CARD-Studie – Bedeutung für die Therapie des fortgeschrittenen Prostatakarzinoms (2020) (0)
Bisphosphonate in der primären Prophylaxe von Metastasen beim Mammakarzinom – neuer Therapiestandard? (2002) (0)
Zielgerichtete Therapie mit liposomalen Arzneimitteln (2001) (0)
Evaluation eines Kommunikationstrainings zur Förderung der frühzeitigen Thematisierung palliativmedizinischer Aspekte bei fortgeschritten erkrankten Krebspatientinnen und -patienten: Studienprotokoll einer randomisierten kontrollierten Studie (PALLI-KOM) [322] (2020) (0)
Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients (2022) (0)
Kolorektales Karzinom beim alten Patienten (2015) (0)
2 Begleitmaßnahmen bei definierter medikamentöser Therapie: Literatur (2006) (0)
Metastasiertes Mammakarzinom: Trastuzumab und Vinorelbine bei HER2-Überexpression (2001) (0)
Adjuvante Radiochemotherapie bei Patienten mit Hochrisikomagenkarzinom (2002) (0)
Allogene Stammzelltransplantation bei soliden Tumoren - Contra (2002) (0)
An exploratory analysis of transfusion risk when initiating darbepoetin alfa (DA) therapy at baseline hemoglobin (Hb) = 10 g/dl in patients (pts) with chemotherapy-induced anemia (CIA). (2010) (0)
Aufbau von Strukturen zur Patientenversorgung (2018) (0)
Frühe Therapieeskalation mit neuen antiandrogenen Substanzen (2018) (0)
Optimierte Therapien beim Urothel-, Nierenzell- und Prostatakarzinom (2020) (0)
Zielgerichtete Tumortherapie (2005) (0)
Versorgung von Patienten nach Krebserkrankung im Kindes-, Jugend- oder jungen Erwachsenenalter (2017) (0)
Prävention der Harnsäurenephropathie (2021) (0)
3. ASORS-Jahreskongress (2013) (0)
AR-V7 – ein neuer prädiktiver und prognostischer Biomarker (2015) (0)
Kardiotoxizität antineoplastischer Substanzen (2018) (0)
"Wirkung des Hypusinierungsinhibitors SAM486A auf Bcr-Abl-positive und -negative Leukämiezellen" (2009) (0)
Qualitätssicherung in der Hämophiliebehandlung (2009) (0)
ESMO-Prüfung für AIO-Mitglieder (2000) (0)
Sterben im Krankenhaus – Optimierung der Versorgung in der Sterbephase (StiK-OV) [266] (2020) (0)
Non-seminomatous testicular germ cell tumours with teratoma-free primaries exhibit a superior early relapse-free survival (2023) (0)
Prophylaxe und Behandlung spezieller Nebenwirkungen von Zytostatika (1998) (0)
Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes (2010) (0)
Neue Follow-up-Daten zu Studien in der Uroonkologie (2022) (0)
‘Neue Therapieperspektiven mit Irinotecan bei gastrointestinalen Tumoren’ 3rd International Conference ‘Perspectives in Colorectal Cancer’ Dublin, 7.–9. Juni 2001 und Wissenschaftliches Symposium Post ASCO. Potsdam, 23.–24. Juni 2001 (2001) (0)
Malignes fibröses Histiozytom (MFH) des Knochens (2006) (0)
Mitteilungen der DGIM (2009) (0)
Fortschritte in der Therapie urogenitaler Tumoren (2016) (0)
Lang erwartete Daten zum Nierenzell- und Prostatakarzinom (2021) (0)
Tumorerkrankung, Therapie und Fatigue (2001) (0)
Mitteilungen onkologischer Gesellschaften (1997) (0)
Multimodale Therapiekonzepte von Keimzelltumoren (2010) (0)
Sarkome des Magens (1997) (0)
Aktuelle Konzepte bei Hodentumoren (1999) (0)
Secondary malignancies following therapy of Hodgkin's disease (HD) (1993) (0)
AIO – Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft e.V. (2004) (0)
28/m mit Rückenschmerzen und Vorwölbung der Bauchwand (2021) (0)
Subject Index Vol. 32, 2009 (2009) (0)
Kardiale Toxizität antineoplastischer Substanzen (2021) (0)
Sachwortverzeichnis Band 21, 1998 (1998) (0)
Paradigmenwechsel beim metastasierten hormonsensitiven Prostatakarzinom (2017) (0)
Atypische Metastasierung eines Urothelkarzinoms der Harnblase (1994) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Gonadotoxizität durch Chemotherapie (2013) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Grundlagen der Eierstock- und Hodenfunktion (2013) (0)
Qualitätsmanagement und Zertifizierung in der Onkologie. Bericht vom DGHO-Symposium anlässlich der DGHO-Jahrestagung am 30.09.2001 in Mannheim (2002) (0)
Offizielles Organ der Deutschen Gesellschaft für Hämatologie und Onkologie, der Österreichischen Gesellschaft für Hämatologie und Onkologie, der Österreichischen Krebsgesellschaft - Krebsliga unter Fortführung der «Österreichischen Zeitung für Onkologie» (2015) (0)
Der Einfluss angeborener Blutungsneigungen auf den sozioökonomischen Status erwachsener Patient – Ergebnisse einer vergleichenden Single-Centre-Kohortenstudie (2017) (0)
Adjuvante Chemotherapie kolorektaler Tumoren (2002) (0)
A–C: Contribution of BCR-ABL and aurora kinase inhibition to the pro-apoptotic effects of Danusertib. (2011) (0)
16 Gonadotoxizität nach medikamentöser Therapie und Radiatio: Literatur (2013) (0)
Dermatotoxizität antineoplastischer Substanzen (2021) (0)
Dauertherapie mit dem Tyrosinkinaseinhibitor Imatinib bei Patienten mit fortgeschrittenem GIST (2007) (0)
Neue Substanzen für die Therapie solider Tumoren (2014) (0)
Metastasiertes Blasenkarzinom in der Zweitlinienbehandlung (2012) (0)
Chemotherapie des metastasierten Blasenkarzinoms (2001) (0)
Neue Entwicklungen in der Tumortherapie (1996) (0)
[Compression syndromes]. (2005) (0)
Neue Kombinationen, BiTE-Antikörper und Antikörper-Wirkstoff-Konjugate bei urogenitalen Tumoren (2019) (0)
Metastasiertes hormonrefraktäres Prostatakarzinom (2007) (0)
PEB ist nicht gleich PEB (2002) (0)
Aus der medizinischen Klinik und Poliklinik II (Hämatologie und Onkologie) Hubertus Wald universitäres Tumorzentrum Universitäres Cancer Center Hamburg des Universitätsklinikums Hamburg-Eppendorf (2011) (0)
Response vs. nonresponse to treatment with erythropoiesis stimulating agents among breast cancer patients with anemia: findings from the European anemia cancer treatment study. (2009) (0)
[31st German Cancer Congress - current developments and discussions in urologic oncology]. (2014) (0)
Einfluss von Angst und Depression bei Angehörigen von Palliativpatienten auf die Einschätzung der Symptombelastung des Patienten (2012) (0)
Die Situation des alten Tumorpatienten (2001) (0)
Circulating Plasma Levels of Bone Morphogenic Protein Antagonist Gremlin-1 Are Increased in Patients with Pulmonary Arterial Hypertension (2012) (0)
A146 Management of Anemia in Multiple Myeloma Patients with Anemia: Findings from the A.C.T. Study (2009) (0)
[Register study for treatment of brain metastases of malignant testicular tumors]. (1998) (0)
[Allogeneic hematopoetic cell transplantation in patients with solid tumors - Contra]. (2002) (0)
843 Role of surgery in patients with liver metastases from nonseminomatous germ cell tumors (2003) (0)
THROMBOSIS AND HEMOSTASIS The polyphosphate – factor XII pathway drives coagulation in prostate cancer-associated thrombosis (2015) (0)
Maligne Hodentumoren (2017) (0)
Poster session 3. Drug profiles – preclinical (2013) (0)
Expression of TGF-β Superfamily Receptor ALK-5 Is Associated with Decreased Overall Survival of AML Patients Receiving Standard AML Chemotherapy. (2009) (0)
[10 years of the Working Group for Geriatric Oncology of the DGHO/DGG/AIO]. (2009) (0)
Incidence of ETV6 Cryptic Translocations In Myeloid Disorders (2010) (0)
Steven Karger (1959–2008) (2008) (0)
921 The role of serum estrogene levels for patients with testicular cancer (1995) (0)
Epidermal growth factor receptor mutations may confer resistance or cross-resistance to cetuximab and panitumumab and can be detected in circulating tumor DNA. (2015) (0)
869 Colorectalcancerdisparities:Issues,controversiesandsolutions (2014) (0)
RETINAL TOXICITY AFTER CISPLATIN‐BASED CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER: MP80‐12 (2017) (0)
Loss of orphan G protein coupled receptor GPRC5A is associated with metastatic disease and poor survival in patients with adenocarcinomas of the lung (2011) (0)
Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study) (2016) (0)
[Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma]. (2007) (0)
Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients (2011) (0)
The Potential Role of Topotecan in the Treatment of Pediatric and Adult Soft-Tissue Sarcomas (1998) (0)
THE VALUE OF POST-CHEMOTHERAPY SURGERY IN THE MANAGEMENT OF PATIENTS HARBOURING LIVER METATASES FROM GERM CELL TUMOURS (2006) (0)
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targeting (2020) (0)
UICC symposium on testicular cancer: Guidelines for standard care and future prospects (1999) (0)
Abstract 3374: Large-scale single-cell whole transcriptomic analyses reveal distinct malignant phenotypes of CTCs from NSCLC patients (2022) (0)
Band 24, Heft 4, August 2001 (2001) (0)
Immuncheckpointinhibition beim Urothelkarzinom (2017) (0)
OAB-049: Poor post-vaccination anti-SARS-CoV-2-antibody response in patients with Multiple Myeloma correlates with low CD19+ B-lymphocyte count and anti-CD38 treatment (2021) (0)
Tumor antigen NY-CO-58/KIF2C is strongly overexpressed in a variety of human cancers and evokes spontaneous T cell responses (2008) (0)
28/m mit Rückenschmerzen und Vorwölbung der Bauchwand (2022) (0)
Experimental Metastasis, Tumor Cell-Induced Coagulopathy and Primary Tumor Growth in Mice with Hemophilia A. (2005) (0)
Evidence that Coagulation Activation Drives Cancer Progression – a Report of 2 Cases (2015) (0)
[Long-term survival in cancer: definitions, concepts, and design principles of survivorship programs]. (2022) (0)
Long-term taxane exposure and transdifferentiation of prostate cancer in vitro. (2023) (0)
Abstract 1189: MERTK is a target in the microenviroenment of osteolytic bone metastasis (2023) (0)
Interleukin-16 Is An Important Growth-Promoting Factor and a Novel Diagnostic and Therapeutic Target for Multiple Myeloma (2010) (0)
Guideline Acute Promyelocytic Leukemia ( APL ) (2016) (0)
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy (2021) (0)
P03.04 MARINE ALKALOID MONANCHOCIDIN: A PROTEOMIC-BASED SCREENING OF PROTEIN TARGETS IN CISPLATIN-RESISTANT TUMOR CELLS (2013) (0)
Retinal toxicity after cisplatin-based chemotherapy in patients with testicular cancer (2017) (0)
Abstract LB-67: Global DNA methylation in fetal human germ cells and germ cell tumors: correlation with differentiation and cisplatin resistance (2010) (0)
Bone Marrow Cellularity, but Not Dysplasia, Is An Additional Prognostic Factor for Patients with Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation (2011) (0)
Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement (2010) (0)
Abstract P5-15-19: Prophylaxis of chemotherapy-induced febrile neutropenia with biosimilar filgrastim: Description of patients, treatment patterns and outcomes in the MONITOR-GCSF study in the breast cancer cohort (2015) (0)
BGB324 Inhibits BCR-ABL TKI-Resistant Chronic Myeloid Leukemia (2015) (0)
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway (2013) (0)
128 Cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen: Interim analysis on treatment associated side effects resulting from a compassionate-use programme (CUP) (2012) (0)
Cisplatin resistance in germ cell tumours: Biological mechanisms and therapeutic avenues (2019) (0)
Comparison of the Management of Anemia in Patients with Solid Versus Hematological Malignancies Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study (2008) (0)
Title Pages / Table of Contents (2009) (0)
EGFRK 521 mediates resistance to Cetuximab in head and neck cancer (2016) (0)
Correlation of pre-treatment serum levels of Magic Roundabout protein with overall survival in patients with advanced non-small cell lung cancer (NSCLC) (2005) (0)
Addition of Darbepoetin Alfa to Sequential High Dose Vip Chemotherapy for Patients with Advanced Metastatic Germ Cell Cancer (2012) (0)
Combination of Imatinib and Hypusination Inhibitors Represents a Novel Therapeutic Strategy in Bcr-Abl Positive Leukemias. (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Carsten Bokemeyer?

Carsten Bokemeyer is affiliated with the following schools:

Monash University
Université catholique de Louvain
Humboldt University of Berlin
University of Rostock
University of Marburg
University of Stuttgart
Hannover Medical School
Cardiff University
University of Hamburg
University of Greifswald